Diego Centonze - Publications

Affiliations: 
 

337 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Gentile A, Musella A, De Vito F, Rizzo FR, Fresegna D, Bullitta S, Vanni V, Guadalupi L, Stampanoni Bassi M, Buttari F, Centonze D, Mandolesi G. Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis. Frontiers in Immunology. 10: 2197. PMID 31572399 DOI: 10.3389/fimmu.2019.02197  0.68
2019 Leocani L, Chieffo R, Gentile A, Centonze D. Beyond rehabilitation in MS: Insights from non-invasive brain stimulation. Multiple Sclerosis (Houndmills, Basingstoke, England). 25: 1363-1371. PMID 31469356 DOI: 10.1177/1352458519865734  0.68
2019 Colamatteo A, Maggioli E, Azevedo Loiola R, Hamid Sheikh M, Calì G, Bruzzese D, Maniscalco GT, Centonze D, Buttari F, Lanzillo R, Perna F, Zuccarelli B, Mottola M, Cassano S, Galgani M, et al. Reduced Annexin A1 Expression Associates with Disease Severity and Inflammation in Multiple Sclerosis Patients. Journal of Immunology (Baltimore, Md. : 1950). PMID 31462505 DOI: 10.4049/jimmunol.1801683  0.48
2019 Stampanoni Bassi M, Iezzi E, Mori F, Simonelli I, Gilio L, Buttari F, Sica F, De Paolis N, Mandolesi G, Musella A, De Vito F, Dolcetti E, Bruno A, Furlan R, Finardi A, ... ... Centonze D, et al. Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis. Neurorehabilitation and Neural Repair. 1545968319868713. PMID 31431121 DOI: 10.1177/1545968319868713  0.76
2019 Grimaldi AE, De Giglio L, Haggiag S, Bianco A, Cortese A, Crisafulli SG, Monteleone F, Marfia G, Prosperini L, Galgani S, Mirabella M, Centonze D, Pozzilli C, Castelli L. The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray). Plos One. 14: e0219670. PMID 31361750 DOI: 10.1371/journal.pone.0219670  0.48
2019 Olivola E, Fasano A, Varanese S, Lena F, Santilli M, Femiano C, Centonze D, Modugno N. Correction to: Continuous subcutaneous apomorphine infusion in Parkinson's disease: causes of discontinuation and subsequent treatment strategies. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. PMID 31257551 DOI: 10.1007/s10072-019-03972-7  0.36
2019 Ciccocioppo F, Lanuti P, Pierdomenico L, Simeone P, Bologna G, Ercolino E, Buttari F, Fantozzi R, Thomas A, Onofrj M, Centonze D, Miscia S, Marchisio M. The Characterization of Regulatory T-Cell Profiles in Alzheimer's Disease and Multiple Sclerosis. Scientific Reports. 9: 8788. PMID 31217537 DOI: 10.1038/s41598-019-45433-3  0.48
2019 Stampanoni Bassi M, Iezzi E, Buttari F, Gilio L, Simonelli I, Carbone F, Micillo T, De Rosa V, Sica F, Furlan R, Finardi A, Fantozzi R, Storto M, Bellantonio P, Pirollo P, ... ... Centonze D, et al. Obesity worsens central inflammation and disability in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519853473. PMID 31161863 DOI: 10.1177/1352458519853473  0.68
2019 Gentile A, De Vito F, Fresegna D, Rizzo FR, Bullitta S, Guadalupi L, Vanni V, Buttari F, Stampanoni Bassi M, Leuti A, Chiurchiù V, Marfia GA, Mandolesi G, Centonze D, Musella A. Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons. Neuropathology and Applied Neurobiology. PMID 31125471 DOI: 10.1111/nan.12569  0.76
2019 Olivola E, Fasano A, Varanese S, Lena F, Santilli M, Femiano C, Centonze D, Modugno N. Continuous subcutaneous apomorphine infusion in Parkinson's disease: causes of discontinuation and subsequent treatment strategies. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. PMID 31111272 DOI: 10.1007/s10072-019-03920-5  0.36
2019 Mandolesi G, Bullitta S, Fresegna D, De Vito F, Rizzo FR, Musella A, Guadalupi L, Vanni V, Stampanoni Bassi M, Buttari F, Viscomi MT, Centonze D, Gentile A. Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination. Neurobiology of Disease. 129: 102-117. PMID 31100354 DOI: 10.1016/j.nbd.2019.05.010  0.68
2019 Liguori C, Ruffini R, Olivola E, Chiaravalloti A, Izzi F, Stefani A, Pierantozzi M, Mercuri NB, Modugno N, Centonze D, Schillaci O, Placidi F. Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study. Parkinsonism & Related Disorders. PMID 30930059 DOI: 10.1016/j.parkreldis.2019.03.017  0.52
2019 Stampanoni Bassi M, Gentile A, Iezzi E, Zagaglia S, Musella A, Simonelli I, Gilio L, Furlan R, Finardi A, Marfia GA, Guadalupi L, Bullitta S, Mandolesi G, Centonze D, Buttari F. Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple Sclerosis. Frontiers in Neurology. 10: 30. PMID 30761069 DOI: 10.3389/fneur.2019.00030  0.76
2019 Nicoletti CG, Monteleone F, Marfia GA, Usiello A, Buttari F, Centonze D, Mori F. Oral D-Aspartate enhances synaptic plasticity reserve in progressive multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519828294. PMID 30730244 DOI: 10.1177/1352458519828294  0.76
2018 Stampanoni Bassi M, Gilio L, Maffei P, Dolcetti E, Bruno A, Buttari F, Centonze D, Iezzi E. Exploiting the Multifaceted Effects of Cannabinoids on Mood to Boost Their Therapeutic Use Against Anxiety and Depression. Frontiers in Molecular Neuroscience. 11: 424. PMID 30515077 DOI: 10.3389/fnmol.2018.00424  0.48
2018 Becher J, Simula L, Volpe E, Procaccini C, La Rocca C, D'Acunzo P, Cianfanelli V, Strappazzon F, Caruana I, Nazio F, Weber G, Gigantino V, Botti G, Ciccosanti F, Borsellino G, ... ... Centonze D, et al. AMBRA1 Controls Regulatory T-Cell Differentiation and Homeostasis Upstream of the FOXO3-FOXP3 Axis. Developmental Cell. 47: 592-607.e6. PMID 30513302 DOI: 10.1016/j.devcel.2018.11.010  0.68
2018 Comi G, Nicoletti F, Canonico PL, Centonze D. Letter to the Editor Regarding: A Comprehensive Review on Copemyl. Neurology and Therapy. PMID 30415356 DOI: 10.1007/s40120-018-0115-y  0.4
2018 Romigi A, Franco V, Placidi F, Liguori C, Rastelli E, Vitrani G, Centonze D, Massa R. Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2. Current Neurology and Neuroscience Reports. 18: 102. PMID 30382420 DOI: 10.1007/s11910-018-0903-x  0.36
2018 Russo C, Riccio E, Pontillo G, Cocozza S, Tedeschi E, Centonze D, Pisani A. Multiple sclerosis and fabry Disease, two sides of the coin? The case of an Italian family. Multiple Sclerosis and Related Disorders. 26: 164-167. PMID 30268036 DOI: 10.1016/j.msard.2018.09.019  0.76
2018 Pieri M, Zenobi R, Morello M, Storto M, Buttari F, Centonze D, Bernardini S, Dessi M. Multiple Sclerosis: kFLC index values related to gender. Multiple Sclerosis and Related Disorders. 26: 58-60. PMID 30223231 DOI: 10.1016/j.msard.2018.08.018  0.56
2018 Stampanoni Bassi M, Iezzi E, Landi D, Monteleone F, Gilio L, Simonelli I, Musella A, Mandolesi G, De Vito F, Furlan R, Finardi A, Marfia GA, Centonze D, Buttari F. Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course. Journal of Neurology. PMID 30167879 DOI: 10.1007/s00415-018-8994-5  0.76
2018 Musella A, Gentile A, Rizzo FR, De Vito F, Fresegna D, Bullitta S, Vanni V, Guadalupi L, Stampanoni Bassi M, Buttari F, Centonze D, Mandolesi G. Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions. Frontiers in Aging Neuroscience. 10: 238. PMID 30135651 DOI: 10.3389/fnagi.2018.00238  0.68
2018 Mirabella M, Prosperini L, Lucchini M, Boffa L, Borriello G, Buscarinu MC, Centonze D, Cortese A, De Fino C, De Giglio L, Elia G, Fantozzi R, Ferraro E, Francia A, Galgani S, et al. Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study. Cns Drugs. PMID 30022464 DOI: 10.1007/s40263-018-0543-3  0.76
2018 Landi D, Ragonese P, Prosperini L, Nociti V, Haggiag S, Cortese A, Fantozzi R, Pontecorvo S, Ferraro E, Buscarinu MC, Mataluni G, Monteleone F, Salvetti M, Di Battista G, Francia A, ... ... Centonze D, et al. Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 29970387 DOI: 10.1136/jnnp-2018-318468  0.76
2018 Prosperini L, Lucchini M, Haggiag S, Bellantonio P, Bianco A, Buscarinu MC, Buttari F, Centonze D, Cortese A, De Giglio L, Fantozzi R, Ferraro E, Fornasiero A, Francia A, Galgani S, et al. Fingolimod vs dimethyl fumarate in multiple sclerosis: A real-world propensity score-matched study. Neurology. PMID 29875218 DOI: 10.1212/WNL.0000000000005772  0.76
2018 Rizzo FR, Musella A, De Vito F, Fresegna D, Bullitta S, Vanni V, Guadalupi L, Stampanoni Bassi M, Buttari F, Mandolesi G, Centonze D, Gentile A. Tumor Necrosis Factor and Interleukin-1 Modulate Synaptic Plasticity during Neuroinflammation. Neural Plasticity. 2018: 8430123. PMID 29861718 DOI: 10.1155/2018/8430123  0.68
2018 Stampanoni Bassi M, Iezzi E, Marfia GA, Simonelli I, Musella A, Mandolesi G, Fresegna D, Pasqualetti P, Furlan R, Finardi A, Mataluni G, Landi D, Gilio L, Centonze D, Buttari F. Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis. Journal of Neuroinflammation. 15: 108. PMID 29655371 DOI: 10.1186/s12974-018-1150-4  0.76
2018 Landi D, Centonze D, Marfia GA, Capra R, Scarpazza C. Do we have enough evidence for recommending therapeutic apheresis for natalizumab-related progressive multifocal leukoencephalopathy patients? Comment on "Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for apheresis: The seventh special issue." Journal of Clinical Apheresis. PMID 29430694 DOI: 10.1002/jca.21616  0.76
2018 Mango D, Nisticò R, Furlan R, Finardi A, Centonze D, Mori F. PDGF Modulates Synaptic Excitability and Short-Latency Afferent Inhibition in Multiple Sclerosis. Neurochemical Research. PMID 29392518 DOI: 10.1007/s11064-018-2484-0  0.48
2018 Gentile A, Musella A, De Vito F, Fresegna D, Bullitta S, Rizzo FR, Centonze D, Mandolesi G. Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake. Journal of Neuroinflammation. 15: 5. PMID 29304807 DOI: 10.1186/s12974-017-1048-6  0.68
2017 Stampanoni Bassi M, Gilio L, Buttari F, Maffei P, Marfia GA, Restivo DA, Centonze D, Iezzi E. Remodeling Functional Connectivity in Multiple Sclerosis: A Challenging Therapeutic Approach. Frontiers in Neuroscience. 11: 710. PMID 29321723 DOI: 10.3389/fnins.2017.00710  0.76
2017 Stampanoni Bassi M, Garofalo S, Marfia GA, Gilio L, Simonelli I, Finardi A, Furlan R, Sancesario GM, Di Giandomenico J, Storto M, Mori F, Centonze D, Iezzi E. Amyloid-β Homeostasis Bridges Inflammation, Synaptic Plasticity Deficits and Cognitive Dysfunction in Multiple Sclerosis. Frontiers in Molecular Neuroscience. 10: 390. PMID 29209169 DOI: 10.3389/fnmol.2017.00390  0.76
2017 Romigi A, Vitrani G, Centonze D, Pierantozzi M. Restless legs syndrome is highly prevalent in patients with postpolio syndrome. Sleep Medicine. PMID 29183652 DOI: 10.1016/j.sleep.2017.09.020  0.36
2017 Monteleone F, Nicoletti CG, Stampanoni Bassi M, Iezzi E, Buttari F, Furlan R, Finardi A, Marfia GA, Centonze D, Mori F. Nerve growth factor is elevated in the CSF of patients with multiple sclerosis and central neuropathic pain. Journal of Neuroimmunology. PMID 29174194 DOI: 10.1016/j.jneuroim.2017.11.012  0.76
2017 Di Giuliano F, Albanese M, Picchi E, Mori F, Buttari F, Marfia GA, Garaci F, Mercuri NB, Floris R, Centonze D, Marziali S. Abnormal cervical lymph nodes in multiple sclerosis: a preliminary ultrasound study. La Radiologia Medica. PMID 29116601 DOI: 10.1007/s11547-017-0829-4  0.76
2017 Chiurchiù V, van der Stelt M, Centonze D, Maccarrone M. The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases. Progress in Neurobiology. PMID 29097192 DOI: 10.1016/j.pneurobio.2017.10.007  0.48
2017 Rossi S, Studer V, Motta C, Polidoro S, Perugini J, Macchiarulo G, Giovannetti AM, Pareja-Gutierrez L, Calò A, Colonna I, Furlan R, Martino G, Centonze D. Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis. Neurology. PMID 28842450 DOI: 10.1212/WNL.0000000000004411  0.6
2017 Colais P, Agabiti N, Davoli M, Buttari F, Centonze D, De Fino C, Di Folco M, Filippini G, Francia A, Galgani S, Gasperini C, Giuliani M, Mirabella M, Nociti V, Pozzilli C, et al. Identifying Relapses in Multiple Sclerosis Patients through Administrative Data: A Validation Study in the Lazio Region, Italy. Neuroepidemiology. 48: 171-178. PMID 28793295 DOI: 10.1159/000479515  0.48
2017 Mandolesi G, Bullitta S, Fresegna D, Gentile A, De Vito F, Dolcetti E, Rizzo FR, Strimpakos G, Centonze D, Musella A. Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum. Neurobiology of Disease. PMID 28757328 DOI: 10.1016/j.nbd.2017.07.019  0.68
2017 Landi D, Albanese M, Buttari F, Monteleone F, Boffa L, Rossi S, Motta C, Puma E, Centonze D. Management of flu-like syndrome with cetirizine in patients with relapsing-remitting multiple sclerosis during therapy with interferon beta: Results of a randomized, cross-over, placebo-controlled pilot study. Plos One. 12: e0165415. PMID 28686675 DOI: 10.1371/journal.pone.0165415  0.6
2017 Studer V, Rocchi C, Motta C, Lauretti B, Perugini J, Brambilla L, Pareja-Gutierrez L, Camera G, Barbieri FR, Marfia GA, Centonze D, Rossi S. Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 3: 2055217317701317. PMID 28607756 DOI: 10.1177/2055217317701317  0.76
2017 Fianco G, Mongiardi MP, Levi A, De Luca T, Desideri M, Trisciuoglio D, Del Bufalo D, Cinà I, Di Benedetto A, Mottolese M, Gentile A, Centonze D, Ferrè F, Barilà D. Caspase-8 contributes to angiogenesis and chemotherapy resistance in glioblastoma. Elife. 6. PMID 28594322 DOI: 10.7554/eLife.22593  0.68
2017 Stampanoni Bassi M, Mori F, Buttari F, Marfia GA, Sancesario A, Centonze D, Iezzi E. Neurophysiology of synaptic functioning in multiple sclerosis. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 128: 1148-1157. PMID 28511127 DOI: 10.1016/j.clinph.2017.04.006  0.76
2017 Buttari F, Zagaglia S, Marciano L, Albanese M, Landi D, Nicoletti CG, Mercuri NB, Silvestrini M, Provinciali L, Marfia GA, Mori F, Centonze D. TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients with relapsing-remitting multiple sclerosis. Journal of Neuroimmunology. 305: 172-174. PMID 28284340 DOI: 10.1016/j.jneuroim.2017.02.007  0.76
2017 Maccarrone M, Maldonado R, Casas M, Henze T, Centonze D. Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others? Expert Review of Clinical Pharmacology. 1-13. PMID 28276775 DOI: 10.1080/17512433.2017.1292849  0.48
2017 Landi D, De Rossi N, Zagaglia S, Scarpazza C, Prosperini L, Albanese M, Buttari F, Mori F, Marfia GA, Sormani MP, Capra R, Centonze D. No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML. Neurology. PMID 28228569 DOI: 10.1212/WNL.0000000000003740  0.76
2017 Mandolesi G, De Vito F, Musella A, Gentile A, Bullitta S, Fresegna D, Sepman H, Di Sanza C, Haji N, Mori F, Buttari F, Perlas E, Ciotti MT, Hornstein E, Bozzoni I, ... ... Centonze D, et al. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 37: 546-561. PMID 28100738 DOI: 10.1523/JNEUROSCI.0851-16.2017  0.68
2016 Mandolesi G, De Vito F, Musella A, Gentile A, Bullitta S, Fresegna D, Sepman H, Di Sanza C, Haji N, Mori F, Buttari F, Perlas E, Teresa Ciotti M, Hornstein E, Bozzoni I, ... ... Centonze D, et al. miR-142-3p is a key regulator of IL-1β-dependent synaptopathy in neuroinflammation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 27920149 DOI: 10.1523/JNEUROSCI.0851-16.2016  0.68
2016 Prosperini L, Saccà F, Cordioli C, Cortese A, Buttari F, Pontecorvo S, Bianco A, Ruggieri S, Haggiag S, Brescia Morra V, Capra R, Centonze D, Di Battista G, Ferraro E, Francia A, et al. Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis. Journal of Neurology. PMID 27878443 DOI: 10.1007/s00415-016-8343-5  0.48
2016 Bacigaluppi M, Russo GL, Peruzzotti-Jametti L, Rossi S, Sandrone S, Butti E, De Ceglia R, Bergamaschi A, Motta C, Gallizioli M, Studer V, Colombo E, Farina C, Comi G, Politi LS, ... ... Centonze D, et al. Neural Stem Cell Transplantation Induces Stroke Recovery by Upregulating Glutamate Transporter GLT-1 in Astrocytes. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 10529-10544. PMID 27733606 DOI: 10.1523/JNEUROSCI.1643-16.2016  0.6
2016 Chiurchiù V, Leuti A, Cencioni MT, Albanese M, De Bardi M, Bisogno T, Centonze D, Battistini L, Maccarrone M. Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors. Pharmacological Research. PMID 27616551 DOI: 10.1016/j.phrs.2016.09.003  0.48
2016 Gentile A, Fresegna D, Musella A, Sepman H, Bullitta S, De Vito F, Fantozzi R, Usiello A, Maccarrone M, Mercuri NB, Lutz B, Mandolesi G, Centonze D. Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis. Journal of Neuroinflammation. 13: 231. PMID 27589957 DOI: 10.1186/s12974-016-0682-8  0.68
2016 Gentile A, Musella A, Bullitta S, Fresegna D, De Vito F, Fantozzi R, Piras E, Gargano F, Borsellino G, Battistini L, Schubart A, Mandolesi G, Centonze D. Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis. Journal of Neuroinflammation. 13: 207. PMID 27566665 DOI: 10.1186/s12974-016-0686-4  0.68
2016 Halper J, Centonze D, Newsome SD, Huang D, Robertson C, You X, Sabatella G, Evilevitch V, Leahy L. Management Strategies for Flu-Like Symptoms and Injection-Site Reactions Associated with Peginterferon Beta-1a: Obtaining Recommendations Using the Delphi Technique. International Journal of Ms Care. 18: 211-8. PMID 27551246 DOI: 10.7224/1537-2073.2015-042  0.68
2016 Catanzaro G, Pucci M, Viscomi MT, Lanuti M, Feole M, Angeletti S, Grasselli G, Mandolesi G, Bari M, Centonze D, D'Addario C, Maccarrone M. Epigenetic modifications of Dexras 1 along the nNOS pathway in an animal model of multiple sclerosis. Journal of Neuroimmunology. 294: 32-40. PMID 27138096 DOI: 10.1016/j.jneuroim.2016.03.009  0.68
2016 Bargagli AM, Colais P, Agabiti N, Mayer F, Buttari F, Centonze D, Di Folco M, Filippini G, Francia A, Galgani S, Gasperini C, Giuliani M, Mirabella M, Nociti V, Pozzilli C, et al. Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems. Journal of Neurology. PMID 26886201 DOI: 10.1007/s00415-016-8049-8  0.68
2016 Albanese M, Zagaglia S, Landi D, Boffa L, Nicoletti CG, Marciani MG, Mandolesi G, Marfia GA, Buttari F, Mori F, Centonze D. Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression. Journal of Neuroinflammation. 13: 36. PMID 26863878 DOI: 10.1186/s12974-016-0502-1  0.68
2016 Motta C, Palermo E, Studer V, Germanotta M, Germani G, Centonze D, Cappa P, Rossi S, Rossi S. Disability and Fatigue Can Be Objectively Measured in Multiple Sclerosis. Plos One. 11: e0148997. PMID 26863109 DOI: 10.1371/journal.pone.0148997  0.6
2016 Mori F, Nisticò R, Nicoletti CG, Zagaglia S, Mandolesi G, Piccinin S, Martino G, Finardi A, Rossini PM, Marfia GA, Furlan R, Centonze D. RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26733422 DOI: 10.1177/1352458515621796  0.76
2015 Ghezzi A, Mutta E, Bianchi F, Bonavita S, Buttari F, Caramma A, Cavarretta R, Centonze D, Coghe GC, Coniglio G, Del Carro U, Ferrò MT, Marrosu MG, Patti F, Rovaris M, et al. Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. PMID 26613723 DOI: 10.1007/s10072-015-2415-7  0.68
2015 Mandolesi G, Gentile A, Musella A, Fresegna D, De Vito F, Bullitta S, Sepman H, Marfia GA, Centonze D. Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis. Nature Reviews. Neurology. PMID 26585978 DOI: 10.1038/nrneurol.2015.222  0.68
2015 Bertoli D, Serana F, Sottini A, Cordioli C, Maimone D, Amato MP, Centonze D, Florio C, Puma E, Capra R, Imberti L. Less Frequent and Less Severe Flu-Like Syndrome in Interferon Beta-1a Treated Multiple Sclerosis Patients with at Least One Allele Bearing the G>C Polymorphism at Position -174 of the IL-6 Promoter Gene. Plos One. 10: e0135441. PMID 26285213 DOI: 10.1371/journal.pone.0135441  0.68
2015 Gentile A, De Vito F, Fresegna D, Musella A, Buttari F, Bullitta S, Mandolesi G, Centonze D. Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis. Frontiers in Cellular Neuroscience. 9: 243. PMID 26161070 DOI: 10.3389/fncel.2015.00243  0.68
2015 Di Mitri D, Sambucci M, Loiarro M, De Bardi M, Volpe E, Cencioni MT, Gasperini C, Centonze D, Sette C, Akbar AN, Borsellino G, Battistini L. The p38 mitogen-activated protein kinase cascade modulates T helper type 17 differentiation and functionality in multiple sclerosis. Immunology. 146: 251-63. PMID 26095162 DOI: 10.1111/imm.12497  0.68
2015 Cencioni MT, Santini S, Ruocco G, Borsellino G, De Bardi M, Grasso MG, Ruggieri S, Gasperini C, Centonze D, Barilá D, Battistini L, Volpe E. FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients. Cell Death & Disease. 6: e1785. PMID 26068793 DOI: 10.1038/cddis.2015.164  0.36
2015 Cencioni MT, Santini S, Ruocco G, Borsellino G, De Bardi M, Grasso MG, Ruggieri S, Gasperini C, Centonze D, Barilá D, Battistini L, Volpe E. FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients. Cell Death & Disease. 6: e1741. PMID 25950471 DOI: 10.1038/cddis.2015.100  0.36
2015 Musella A, Mandolesi G, Mori F, Gentile A, Centonze D. Linking synaptopathy and gray matter damage in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 25921048 DOI: 10.1177/1352458515581875  0.68
2015 Parodi B, Rossi S, Morando S, Cordano C, Bragoni A, Motta C, Usai C, Wipke BT, Scannevin RH, Mancardi GL, Centonze D, Kerlero de Rosbo N, Uccelli A. Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS. Acta Neuropathologica. 130: 279-95. PMID 25920452 DOI: 10.1007/s00401-015-1422-3  0.68
2015 Mechelli R, Manzari C, Policano C, Annese A, Picardi E, Umeton R, Fornasiero A, D'Erchia AM, Buscarinu MC, Agliardi C, Annibali V, Serafini B, Rosicarelli B, Romano S, Angelini DF, ... ... Centonze D, et al. Epstein-Barr virus genetic variants are associated with multiple sclerosis. Neurology. 84: 1362-8. PMID 25740864 DOI: 10.1212/WNL.0000000000001420  0.68
2015 Ruocco G, Rossi S, Motta C, Macchiarulo G, Barbieri F, De Bardi M, Borsellino G, Finardi A, Grasso MG, Ruggieri S, Gasperini C, Furlan R, Centonze D, Battistini L, Volpe E. T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis. Clinical Science (London, England : 1979). 129: 291-303. PMID 25700150 DOI: 10.1042/CS20140608  0.68
2015 Prosperini L, Annovazzi P, Capobianco M, Capra R, Buttari F, Gasperini C, Galgani S, Solaro C, Centonze D, Bertolotto A, Pozzilli C, Ghezzi A. Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 25698174 DOI: 10.1177/1352458515570768  0.68
2015 Rossi S, Studer V, Motta C, Centonze D. Paroxysmal dysarthria-ataxia syndrome resolving after fingolimod treatment. Journal of the Neurological Sciences. 350: 101-2. PMID 25676590 DOI: 10.1016/j.jns.2015.01.023  0.68
2015 Stüve O, Centonze D. Treatment decisions for patients with active multiple sclerosis. Jama Neurology. 72: 387-9. PMID 25664937 DOI: 10.1001/jamaneurol.2014.4494  0.68
2015 Gentile A, Mori F, Bernardini S, Centonze D. Role of amyloid-β CSF levels in cognitive deficit in MS. Clinica Chimica Acta; International Journal of Clinical Chemistry. PMID 25659291 DOI: 10.1016/j.cca.2015.01.035  0.68
2015 Rossi S, Motta C, Studer V, Macchiarulo G, Germani G, Finardi A, Furlan R, Martino G, Centonze D. Subclinical central inflammation is risk for RIS and CIS conversion to MS. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 25583841 DOI: 10.1177/1352458514564482  0.68
2015 Gentile A, Fresegna D, Federici M, Musella A, Rizzo FR, Sepman H, Bullitta S, De Vito F, Haji N, Rossi S, Mercuri NB, Usiello A, Mandolesi G, Centonze D. Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis. Neurobiology of Disease. 74: 347-58. PMID 25511803 DOI: 10.1016/j.nbd.2014.11.022  0.68
2015 Di Marzo V, Centonze D. Placebo effects in a multiple sclerosis spasticity enriched clinical trial with the oromucosal cannabinoid spray (THC/CBD): dimension and possible causes. Cns Neuroscience & Therapeutics. 21: 215-21. PMID 25475413 DOI: 10.1111/cns.12358  0.68
2015 Mandolesi G, Gentile A, Musella A, Centonze D. IL-1β dependent cerebellar synaptopathy in a mouse mode of multiple sclerosis. Cerebellum (London, England). 14: 19-22. PMID 25326653 DOI: 10.1007/s12311-014-0613-0  0.68
2015 Rossi S, Motta C, Musella A, Centonze D. The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission. Neuropharmacology. 96: 105-12. PMID 25268960 DOI: 10.1016/j.neuropharm.2014.09.022  0.68
2015 Monteleone F, Buccisano F, Boffa L, Buttari F, Di Veroli A, Borriello G, Rossi S, Centonze D. Reversible hyporegenerative anemia during natalizumab treatment. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 257-8. PMID 25186208 DOI: 10.1177/1352458514546516  0.68
2015 Rossi S, Rocchi C, Studer V, Motta C, Lauretti B, Germani G, Macchiarulo G, Marfia GA, Centonze D. The autonomic balance predicts cardiac responses after the first dose of fingolimod. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 206-16. PMID 24957049 DOI: 10.1177/1352458514538885  0.68
2015 Rieckmann P, Boyko A, Centonze D, Elovaara I, Giovannoni G, Havrdová E, Hommes O, Kesselring J, Kobelt G, Langdon D, Lelorier J, Morrow SA, Oreja-Guevara C, Schippling S, Thalheim C, et al. Achieving patient engagement in multiple sclerosis: A perspective from the multiple sclerosis in the 21st Century Steering Group Multiple Sclerosis and Related Disorders. 4: 202-218. DOI: 10.1016/j.msard.2015.02.005  0.68
2014 Mori F, Ljoka C, Nicoletti CG, Kusayanagi H, Buttari F, Giordani L, Rossi S, Foti C, Centonze D. CB1 receptor affects cortical plasticity and response to physiotherapy in multiple sclerosis. Neurology® Neuroimmunology & Neuroinflammation. 1: e48. PMID 25520956 DOI: 10.1212/NXI.0000000000000048  0.6
2014 Rossi S, Motta C, Studer V, Macchiarulo G, Volpe E, Barbieri F, Ruocco G, Buttari F, Finardi A, Mancino R, Weiss S, Battistini L, Martino G, Furlan R, Drulovic J, ... Centonze D, et al. Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53. Molecular Neurodegeneration. 9: 56. PMID 25495224 DOI: 10.1186/1750-1326-9-56  0.6
2014 Centonze D. Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways. European Neurology. 72: 6-8. PMID 25278116 DOI: 10.1159/000367615  0.68
2014 Studer V, Rossi S, Motta C, Buttari F, Centonze D. Peripheral B cell depletion and central proinflammatory cytokine reduction following repeated intrathecal administration of rituximab in progressive Multiple Sclerosis. Journal of Neuroimmunology. 276: 229-31. PMID 25175066 DOI: 10.1016/j.jneuroim.2014.08.617  0.68
2014 Errico F, Nisticò R, Di Giorgio A, Squillace M, Vitucci D, Galbusera A, Piccinin S, Mango D, Fazio L, Middei S, Trizio S, Mercuri NB, Teule MA, Centonze D, Gozzi A, et al. Free D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammals. Translational Psychiatry. 4: e417. PMID 25072322 DOI: 10.1038/tp.2014.59  0.68
2014 Stüve O, Warnke C, Deason K, Stangel M, Kieseier BC, Hartung HP, von Büdingen HC, Centonze D, Forsthuber TG, Knappertz V. CD19 as a molecular target in CNS autoimmunity. Acta Neuropathologica. 128: 177-90. PMID 24993505 DOI: 10.1007/s00401-014-1313-z  0.68
2014 Laricchiuta D, Musella A, Rossi S, Centonze D. Behavioral and electrophysiological effects of endocannabinoid and dopaminergic systems on salient stimuli. Frontiers in Behavioral Neuroscience. 8: 183. PMID 24904335 DOI: 10.3389/fnbeh.2014.00183  0.68
2014 Rossi S, Motta C, Studer V, Rocchi C, Macchiarulo G, Barbieri F, Marfia G, Furlan R, Martino G, Mancino R, Centonze D. Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1841-50. PMID 24876157 DOI: 10.1177/1352458514537365  0.68
2014 Rossi S, Motta C, Studer V, Boffa L, De Chiara V, Castelli M, Barbieri F, Buttari F, Monteleone F, Germani G, Macchiarulo G, Weiss S, Centonze D. Treatment options to reduce disease activity after natalizumab: paradoxical effects of corticosteroids. Cns Neuroscience & Therapeutics. 20: 748-53. PMID 24837039 DOI: 10.1111/cns.12282  0.68
2014 Weiss S, Mori F, Rossi S, Centonze D. Disability in multiple sclerosis: when synaptic long-term potentiation fails. Neuroscience and Biobehavioral Reviews. 43: 88-99. PMID 24726576 DOI: 10.1016/j.neubiorev.2014.03.023  0.68
2014 Laroni A, Brogi D, Morra VB, Guidi L, Pozzilli C, Comi G, Lugaresi A, Turrini R, Raimondi D, Uccelli A, Mancardi GL, Amato MP, Appendino L, Ardito B, Avolio C, ... ... Centonze D, et al. Safety of the first dose of fingolimod for multiple sclerosis: Results of an open-label clinical trial Bmc Neurology. 14. PMID 24690227 DOI: 10.1186/1471-2377-14-65  0.68
2014 Mori F, Nicoletti CG, Rossi S, Motta C, Kusayanagi H, Bergami A, Studer V, Buttari F, Barbieri F, Weiss S, Nisticò R, Martino G, Furlan R, Centonze D. Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosis. Neuromolecular Medicine. 16: 490-8. PMID 24671722 DOI: 10.1007/s12017-014-8297-7  0.68
2014 Rossi S, Studer V, Motta C, Germani G, Macchiarulo G, Buttari F, Mancino R, Castelli M, De Chiara V, Weiss S, Martino G, Furlan R, Centonze D. Cerebrospinal fluid detection of interleukin-1β in phase of remission predicts disease progression in multiple sclerosis. Journal of Neuroinflammation. 11: 32. PMID 24548694 DOI: 10.1186/1742-2094-11-32  0.68
2014 Stefanini M, Fabiano S, Garaci F, Marziali S, Meschini A, Cama V, Fornari M, Rossi S, Centonze D, Gandini R, Simonetti G, Floris R. Phlebographic study does not show differences between patients with MS and control subjects. Ajnr. American Journal of Neuroradiology. 35: 1174-9. PMID 24524919 DOI: 10.3174/ajnr.A3816  0.68
2014 Prosperini L, Mancinelli CR, Pozzilli C, Grasso MG, Clemenzi A, Collorone S, Pontecorvo S, Francia A, Villani V, Koudriavtseva T, Buttari F, Centonze D, Di Battista G, Frisullo G, Galgani S, et al. From high- to low-frequency administered interferon-beta for multiple sclerosis: a multicenter study. European Neurology. 71: 233-41. PMID 24480868 DOI: 10.1159/000356786  0.68
2014 Musella A, Sepman H, Mandolesi G, Gentile A, Fresegna D, Haji N, Conrad A, Lutz B, Maccarrone M, Centonze D. Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis. Neuropharmacology. 79: 567-72. PMID 24440366 DOI: 10.1016/j.neuropharm.2014.01.007  0.68
2014 Bertolotto A, Capobianco M, Amato MP, Capello E, Capra R, Centonze D, Di Ioia M, Gallo A, Grimaldi L, Imberti L, Lugaresi A, Mancinelli C, Marrosu MG, Moiola L, Montanari E, et al. Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 35: 307-16. PMID 24374787 DOI: 10.1007/s10072-013-1616-1  0.68
2014 Nisticò R, Mori F, Feligioni M, Nicoletti F, Centonze D. Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 369: 20130162. PMID 24298163 DOI: 10.1098/rstb.2013.0162  0.68
2014 Mori F, Kusayanagi H, Nicoletti CG, Weiss S, Marciani MG, Centonze D. Cortical plasticity predicts recovery from relapse in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 451-7. PMID 24263385 DOI: 10.1177/1352458513512541  0.68
2014 Mori F, Nisticò R, Mandolesi G, Piccinin S, Mango D, Kusayanagi H, Berretta N, Bergami A, Gentile A, Musella A, Nicoletti CG, Nicoletti F, Buttari F, Mercuri NB, Martino G, ... ... Centonze D, et al. Interleukin-1β promotes long-term potentiation in patients with multiple sclerosis. Neuromolecular Medicine. 16: 38-51. PMID 23892937 DOI: 10.1007/s12017-013-8249-7  0.68
2014 Rossi S, Motta C, Studer V, Barbieri F, Buttari F, Bergami A, Sancesario G, Bernardini S, De Angelis G, Martino G, Furlan R, Centonze D. Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 304-12. PMID 23886826 DOI: 10.1177/1352458513498128  0.68
2014 Pieri M, Duranti F, Centonze D, Buttari F, Bernardini S, Dessì M. K Index in cerebrospinal fluid: a valid tool in multiple sclerosis diagnosis Rivista Italiana Della Medicina Di Laboratorio. 10: 167-171. DOI: 10.1007/s13631-014-0072-0  0.68
2013 Rossi S, Bozzali M, Bari M, Mori F, Studer V, Motta C, Buttari F, Cercignani M, Gravina P, Mastrangelo N, Castelli M, Mancino R, Nucci C, Sottile F, Bernardini S, ... ... Centonze D, et al. Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis. Plos One. 8: e82848. PMID 24391723 DOI: 10.1371/journal.pone.0082848  0.68
2013 Basile B, Castelli M, Monteleone F, Nocentini U, Caltagirone C, Centonze D, Cercignani M, Bozzali M. Functional connectivity changes within specific networks parallel the clinical evolution of multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1050-1057. PMID 24326671 DOI: 10.1177/1352458513515082  0.68
2013 Mori F, Rossi S, Piccinin S, Motta C, Mango D, Kusayanagi H, Bergami A, Studer V, Nicoletti CG, Buttari F, Barbieri F, Mercuri NB, Martino G, Furlan R, Nisticò R, ... Centonze D, et al. Synaptic plasticity and PDGF signaling defects underlie clinical progression in multiple sclerosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 19112-9. PMID 24305808 DOI: 10.1523/JNEUROSCI.2536-13.2013  0.68
2013 Musella A, Mandolesi G, Gentile A, Rossi S, Studer V, Motta C, Sepman H, Fresegna D, Haji N, Paolillo A, Matarese G, Centonze D. Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis. Journal of Neuroimmunology. 264: 8-13. PMID 24045165 DOI: 10.1016/j.jneuroim.2013.08.009  0.68
2013 Laricchiuta D, Centonze D, Petrosini L. Effects of endocannabinoid and endovanilloid systems on aversive memory extinction. Behavioural Brain Research. 256: 101-7. PMID 23948212 DOI: 10.1016/j.bbr.2013.08.010  0.68
2013 Duranti F, Pieri M, Centonze D, Buttari F, Bernardini S, Dessi M. Determination of κFLC and κ Index in cerebrospinal fluid: a valid alternative to assess intrathecal immunoglobulin synthesis. Journal of Neuroimmunology. 263: 116-20. PMID 23916392 DOI: 10.1016/j.jneuroim.2013.07.006  0.68
2013 Mandolesi G, Musella A, Gentile A, Grasselli G, Haji N, Sepman H, Fresegna D, Bullitta S, De Vito F, Musumeci G, Di Sanza C, Strata P, Centonze D. Interleukin-1β alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 12105-21. PMID 23864696 DOI: 10.1523/JNEUROSCI.5369-12.2013  0.68
2013 De Chiara V, Motta C, Rossi S, Studer V, Barbieri F, Lauro D, Bernardi G, Centonze D. Interleukin-1β alters the sensitivity of cannabinoid CB1 receptors controlling glutamate transmission in the striatum. Neuroscience. 250: 232-9. PMID 23856068 DOI: 10.1016/j.neuroscience.2013.06.069  0.68
2013 Rossi S, Studer V, Moscatelli A, Motta C, Coghe G, Fenu G, Caillier S, Buttari F, Mori F, Barbieri F, Castelli M, De Chiara V, Monteleone F, Mancino R, Bernardi G, ... ... Centonze D, et al. Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis. Plos One. 8: e67357. PMID 23840674 DOI: 10.1371/journal.pone.0067357  0.68
2013 Bari M, Battista N, Valenza M, Mastrangelo N, Malaponti M, Catanzaro G, Centonze D, Finazzi-Agrò A, Cattaneo E, Maccarrone M. In vitro and in vivo models of Huntington's disease show alterations in the endocannabinoid system. The Febs Journal. 280: 3376-88. PMID 23659592 DOI: 10.1111/febs.12329  0.68
2013 Angelini DF, Serafini B, Piras E, Severa M, Coccia EM, Rosicarelli B, Ruggieri S, Gasperini C, Buttari F, Centonze D, Mechelli R, Salvetti M, Borsellino G, Aloisi F, Battistini L. Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis. Plos Pathogens. 9: e1003220. PMID 23592979 DOI: 10.1371/journal.ppat.1003220  0.68
2013 Chiurchiù V, Cencioni MT, Bisicchia E, De Bardi M, Gasperini C, Borsellino G, Centonze D, Battistini L, Maccarrone M. Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis. Annals of Neurology. 73: 626-36. PMID 23447381 DOI: 10.1002/ana.23875  0.68
2013 Gentile A, Rossi S, Studer V, Motta C, De Chiara V, Musella A, Sepman H, Fresegna D, Musumeci G, Grasselli G, Haji N, Weiss S, Hayardeny L, Mandolesi G, Centonze D. Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 8: 651-63. PMID 23370991 DOI: 10.1007/s11481-013-9436-x  0.68
2013 Nisticò R, Mango D, Mandolesi G, Piccinin S, Berretta N, Pignatelli M, Feligioni M, Musella A, Gentile A, Mori F, Bernardi G, Nicoletti F, Mercuri NB, Centonze D. Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis. Plos One. 8: e54666. PMID 23355887 DOI: 10.1371/journal.pone.0054666  0.68
2013 Bozzali M, Spanò B, Parker GJ, Giulietti G, Castelli M, Basile B, Rossi S, Serra L, Magnani G, Nocentini U, Caltagirone C, Centonze D, Cercignani M. Anatomical brain connectivity can assess cognitive dysfunction in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1161-8. PMID 23325589 DOI: 10.1177/1352458512474088  0.68
2013 Pieragostino D, Del Boccio P, Di Ioia M, Pieroni L, Greco V, De Luca G, D'Aguanno S, Rossi C, Franciotta D, Centonze D, Sacchetta P, Di Ilio C, Lugaresi A, Urbani A. Oxidative modifications of cerebral transthyretin are associated with multiple sclerosis. Proteomics. 13: 1002-9. PMID 23319365 DOI: 10.1002/pmic.201200395  0.68
2013 Ruffini F, Rossi S, Bergamaschi A, Brambilla E, Finardi A, Motta C, Studer V, Barbieri F, De Chiara V, Hayardeny L, Comi G, Centonze D, Martino G. Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1084-94. PMID 23232603 DOI: 10.1177/1352458512469698  0.68
2013 Mori F, Nicoletti CG, Kusayanagi H, Foti C, Restivo DA, Marciani MG, Centonze D. Transcranial direct current stimulation ameliorates tactile sensory deficit in multiple sclerosis. Brain Stimulation. 6: 654-9. PMID 23122918 DOI: 10.1016/j.brs.2012.10.003  0.68
2013 Restivo DA, Casabona A, Centonze D, Marchese-Ragona R, Maimone D, Pavone A. Pharyngeal electrical stimulation for dysphagia associated with multiple sclerosis: a pilot study. Brain Stimulation. 6: 418-23. PMID 23040375 DOI: 10.1016/j.brs.2012.09.001  0.68
2013 Rieckmann P, Boyko A, Centonze D, Coles A, Elovaara I, Havrdová E, Hommes O, Lelorier J, Morrow SA, Oreja-Guevara C, Rijke N, Schippling S. Future MS care: a consensus statement of the MS in the 21st Century Steering Group. Journal of Neurology. 260: 462-9. PMID 22936203 DOI: 10.1007/s00415-012-6656-6  0.68
2013 Grasselli G, Rossi S, Musella A, Gentile A, Loizzo S, Muzio L, Di Sanza C, Errico F, Musumeci G, Haji N, Fresegna D, Sepman H, De Chiara V, Furlan R, Martino G, ... ... Centonze D, et al. Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis. British Journal of Pharmacology. 168: 502-17. PMID 22924679 DOI: 10.1111/j.1476-5381.2012.02178.x  0.68
2013 Rossi S, Motta C, Studer V, De Chiara V, Barbieri F, Monteleone F, Fornasiero A, Coarelli G, Bernardi G, Cutter G, Stüve O, Salvetti M, Centonze D. Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 20: 87-94. PMID 22741530 DOI: 10.1111/j.1468-1331.2012.03794.x  0.68
2013 Rossi S, Motta C, Studer V, Monteleone F, De Chiara V, Buttari F, Barbieri F, Bernardi G, Battistini L, Cutter G, Stüve O, Salvetti M, Centonze D. A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 59-68. PMID 22577119 DOI: 10.1177/1352458512448106  0.68
2013 Mori F, Kusayanagi H, Monteleone F, Moscatelli A, Nicoletti CG, Bernardi G, Centonze D. Short interval intracortical facilitation correlates with the degree of disability in multiple sclerosis. Brain Stimulation. 6: 67-71. PMID 22425067 DOI: 10.1016/j.brs.2012.02.001  0.68
2012 Mori F, Kusayanagi H, Buttari F, Centini B, Monteleone F, Nicoletti CG, Bernardi G, Di Cantogno EV, Marciani MG, Centonze D. Early treatment with high-dose interferon beta-1a reverses cognitive and cortical plasticity deficits in multiple sclerosis. Functional Neurology. 27: 163-8. PMID 23402677  0.68
2012 Saraceno R, Faleri S, Ruzzetti M, Centonze D, Chimenti S. Prevalence and management of panic attacks during infliximab infusion in psoriatic patients. Dermatology (Basel, Switzerland). 225: 236-41. PMID 23183380 DOI: 10.1159/000343609  0.68
2012 Rossi S, Sacchetti L, Napolitano F, De Chiara V, Motta C, Studer V, Musella A, Barbieri F, Bari M, Bernardi G, Maccarrone M, Usiello A, Centonze D. Interleukin-1β causes anxiety by interacting with the endocannabinoid system. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 13896-905. PMID 23035099 DOI: 10.1523/JNEUROSCI.1515-12.2012  0.68
2012 Centonze D, Rossi S, Rinaldi F, Gallo P. Severe relapses under fingolimod treatment prescribed after natalizumab. Neurology. 79: 2004-5. PMID 23035063 DOI: 10.1212/WNL.0b013e3182735c7a  0.68
2012 Butti E, Bacigaluppi M, Rossi S, Cambiaghi M, Bari M, Cebrian Silla A, Brambilla E, Musella A, De Ceglia R, Teneud L, De Chiara V, D'Adamo P, Garcia-Verdugo JM, Comi G, Muzio L, ... ... Centonze D, et al. Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity. Brain : a Journal of Neurology. 135: 3320-35. PMID 23008234 DOI: 10.1093/brain/aws194  0.68
2012 Garaci FG, Marziali S, Meschini A, Fornari M, Rossi S, Melis M, Fabiano S, Stefanini M, Simonetti G, Centonze D, Floris R. Brain hemodynamic changes associated with chronic cerebrospinal venous insufficiency are not specific to multiple sclerosis and do not increase its severity. Radiology. 265: 233-9. PMID 22915599 DOI: 10.1148/radiol.12112245  0.68
2012 Haji N, Mandolesi G, Gentile A, Sacchetti L, Fresegna D, Rossi S, Musella A, Sepman H, Motta C, Studer V, De Chiara V, Bernardi G, Strata P, Centonze D. TNF-α-mediated anxiety in a mouse model of multiple sclerosis. Experimental Neurology. 237: 296-303. PMID 22836148 DOI: 10.1016/j.expneurol.2012.07.010  0.68
2012 Rossi S, Studer V, Motta C, De Chiara V, Barbieri F, Bernardi G, Centonze D. Inflammation inhibits GABA transmission in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 1633-5. PMID 22419673 DOI: 10.1177/1352458512440207  0.68
2012 Laricchiuta D, Rossi S, Musella A, De Chiara V, Cutuli D, Centonze D, Petrosini L. Differences in spontaneously avoiding or approaching mice reflect differences in CB1-mediated signaling of dorsal striatal transmission. Plos One. 7: e33260. PMID 22413007 DOI: 10.1371/journal.pone.0033260  0.68
2012 Lugaresi A, Florio C, Brescia-Morra V, Cottone S, Bellantonio P, Clerico M, Centonze D, Uccelli A, di Ioia M, De Luca G, Marcellusi A, Paolillo A. Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study. Bmc Neurology. 12: 7. PMID 22390218 DOI: 10.1186/1471-2377-12-7  0.68
2012 Mandolesi G, Grasselli G, Musella A, Gentile A, Musumeci G, Sepman H, Haji N, Fresegna D, Bernardi G, Centonze D. GABAergic signaling and connectivity on Purkinje cells are impaired in experimental autoimmune encephalomyelitis. Neurobiology of Disease. 46: 414-24. PMID 22349452 DOI: 10.1016/j.nbd.2012.02.005  0.68
2012 Rossi S, Furlan R, De Chiara V, Motta C, Studer V, Mori F, Musella A, Bergami A, Muzio L, Bernardi G, Battistini L, Martino G, Centonze D. Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis. Annals of Neurology. 71: 76-83. PMID 22275254 DOI: 10.1002/ana.22512  0.68
2012 Mori F, Ribolsi M, Kusayanagi H, Monteleone F, Mantovani V, Buttari F, Marasco E, Bernardi G, Maccarrone M, Centonze D. TRPV1 channels regulate cortical excitability in humans. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 873-9. PMID 22262885 DOI: 10.1523/JNEUROSCI.2531-11.2012  0.68
2012 Floris R, Centonze D, Fabiano S, Stefanini M, Marziali S, Del Giudice C, Reale CA, Castelli M, Garaci F, Melis M, Gandini R, Simonetti G. Prevalence study of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: preliminary data. La Radiologia Medica. 117: 855-64. PMID 22228125 DOI: 10.1007/s11547-011-0767-5  0.68
2012 Oddi S, Dainese E, Sandiford S, Fezza F, Lanuti M, Chiurchiù V, Totaro A, Catanzaro G, Barcaroli D, De Laurenzi V, Centonze D, Mukhopadhyay S, Selent J, Howlett AC, Maccarrone M. Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signalling. British Journal of Pharmacology. 165: 2635-51. PMID 21895628 DOI: 10.1111/j.1476-5381.2011.01658.x  0.68
2012 Rossi S, Lo Giudice T, De Chiara V, Musella A, Studer V, Motta C, Bernardi G, Martino G, Furlan R, Martorana A, Centonze D. Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis. British Journal of Pharmacology. 165: 861-9. PMID 21740406 DOI: 10.1111/j.1476-5381.2011.01579.x  0.68
2012 Gironi M, Pasquariello N, Franchi S, Pucci M, Martinelli-Boneschi F, Solaro C, Centonze D, Martino G, Sacerdote P, Maccarrone M. Comment on "Cannabinoid receptor and N-acyl phosphatidylethanolamine phospholipase D--evidence for altered expression in multiple sclerosis". Brain Pathology (Zurich, Switzerland). 22: 79. PMID 21707818 DOI: 10.1111/j.1750-3639.2011.00511.x  0.68
2012 Filomeni G, Graziani I, De Zio D, Dini L, Centonze D, Rotilio G, Ciriolo MR. Neuroprotection of kaempferol by autophagy in models of rotenone-mediated acute toxicity: possible implications for Parkinson's disease. Neurobiology of Aging. 33: 767-85. PMID 20594614 DOI: 10.1016/j.neurobiolaging.2010.05.021  0.68
2011 Castelli M, Federici M, Rossi S, De Chiara V, Napolitano F, Studer V, Motta C, Sacchetti L, Romano R, Musella A, Bernardi G, Siracusano A, Gu HH, Mercuri NB, Usiello A, ... Centonze D, et al. Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter. The European Journal of Neuroscience. 34: 1369-77. PMID 22034972 DOI: 10.1111/j.1460-9568.2011.07876.x  0.68
2011 Centonze D, Floris R, Stefanini M, Rossi S, Fabiano S, Castelli M, Marziali S, Spinelli A, Motta C, Garaci FG, Bernardi G, Simonetti G. Proposed chronic cerebrospinal venous insufficiency criteria do not predict multiple sclerosis risk or severity. Annals of Neurology. 70: 51-8. PMID 21786298 DOI: 10.1002/ana.22436  0.68
2011 Mori F, Ribolsi M, Kusayanagi H, Siracusano A, Mantovani V, Marasco E, Bernardi G, Centonze D. Genetic variants of the NMDA receptor influence cortical excitability and plasticity in humans. Journal of Neurophysiology. 106: 1637-43. PMID 21753020 DOI: 10.1152/jn.00318.2011  0.68
2011 Dalla Libera D, Di Mitri D, Bergami A, Centonze D, Gasperini C, Grasso MG, Galgani S, Martinelli V, Comi G, Avolio C, Martino G, Borsellino G, Sallusto F, Battistini L, Furlan R. T regulatory cells are markers of disease activity in multiple sclerosis patients. Plos One. 6: e21386. PMID 21731726 DOI: 10.1371/journal.pone.0021386  0.68
2011 Rossi S, Mancino R, Bergami A, Mori F, Castelli M, De Chiara V, Studer V, Mataluni G, Sancesario G, Parisi V, Kusayanagi H, Bernardi G, Nucci C, Bernardini S, Martino G, ... ... Centonze D, et al. Potential role of IL-13 in neuroprotection and cortical excitability regulation in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 1301-12. PMID 21677024 DOI: 10.1177/1352458511410342  0.68
2011 Musumeci G, Grasselli G, Rossi S, De Chiara V, Musella A, Motta C, Studer V, Bernardi G, Haji N, Sepman H, Fresegna D, Maccarrone M, Mandolesi G, Centonze D. Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis. Neurobiology of Disease. 43: 669-77. PMID 21672630 DOI: 10.1016/j.nbd.2011.05.018  0.68
2011 Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Picconi O, Cilia S, Cottone S, Centonze D, Gasperini C. Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 991-1001. PMID 21502310 DOI: 10.1177/1352458511401943  0.68
2011 Rossi S, Furlan R, De Chiara V, Muzio L, Musella A, Motta C, Studer V, Cavasinni F, Bernardi G, Martino G, Cravatt BF, Lutz B, Maccarrone M, Centonze D. Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis. Brain, Behavior, and Immunity. 25: 1242-8. PMID 21473912 DOI: 10.1016/j.bbi.2011.03.017  0.68
2011 Hasan SK, Buttari F, Ottone T, Voso MT, Hohaus S, Marasco E, Mantovani V, Garagnani P, Sanz MA, Cicconi L, Bernardi G, Centonze D, Lo-Coco F. Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes. Neurology. 76: 1059-65. PMID 21346221 DOI: 10.1212/WNL.0b013e318211c3c8  0.68
2011 Maccarrone M, Bernardi G, Agrò AF, Centonze D. Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance. British Journal of Pharmacology. 163: 1379-90. PMID 21323908 DOI: 10.1111/j.1476-5381.2011.01277.x  0.68
2011 Bagnato F, Centonze D, Galgani S, Grasso MG, Haggiag S, Strano S. Painful and involuntary multiple sclerosis. Expert Opinion On Pharmacotherapy. 12: 763-77. PMID 21323633 DOI: 10.1517/14656566.2011.540239  0.68
2011 Mori F, Ljoka C, Magni E, Codecà C, Kusayanagi H, Monteleone F, Sancesario A, Bernardi G, Koch G, Foti C, Centonze D. Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. Journal of Neurology. 258: 1281-7. PMID 21286740 DOI: 10.1007/s00415-011-5924-1  0.68
2011 Ghezzi A, Grimaldi LM, Marrosu MG, Pozzilli C, Comi G, Bertolotto A, Trojano M, Gallo P, Capra R, Centonze D, Millefiorini E, Sotgiu S, Brescia Morra V, Amato MP, Lugaresi A, et al. Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group--Italian Neurological Society. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 32: 351-8. PMID 21234775 DOI: 10.1007/s10072-010-0469-0  0.68
2011 Oddi S, Dainese E, Fezza F, Lanuti M, Barcaroli D, De Laurenzi V, Centonze D, Maccarrone M. Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor. Journal of Neurochemistry. 116: 858-65. PMID 21214565 DOI: 10.1111/j.1471-4159.2010.07041.x  0.68
2011 Cutuli D, Rossi S, Burello L, Laricchiuta D, De Chiara V, Foti F, De Bartolo P, Musella A, Gelfo F, Centonze D, Petrosini L. Before or after does it matter? Different protocols of environmental enrichment differently influence motor, synaptic and structural deficits of cerebellar origin. Neurobiology of Disease. 42: 9-20. PMID 21182946 DOI: 10.1016/j.nbd.2010.12.007  0.68
2011 Rossi S, Buttari F, Studer V, Motta C, Gravina P, Castelli M, Mantovani V, De Chiara V, Musella A, Fiore S, Masini S, Bernardi G, Maccarrone M, Bernardini S, Centonze D. The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 281-8. PMID 21148019 DOI: 10.1177/1352458510388680  0.68
2011 Mori F, Rossi S, Sancesario G, Codecà C, Mataluni G, Monteleone F, Buttari F, Kusayanagi H, Castelli M, Motta C, Studer V, Bernardi G, Koch G, Bernardini S, Centonze D. Cognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 559-68. PMID 20944553 DOI: 10.1038/npp.2010.187  0.68
2011 Rossi S, Muzio L, De Chiara V, Grasselli G, Musella A, Musumeci G, Mandolesi G, De Ceglia R, Maida S, Biffi E, Pedrocchi A, Menegon A, Bernardi G, Furlan R, Martino G, ... Centonze D, et al. Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis. Brain, Behavior, and Immunity. 25: 947-56. PMID 20940040 DOI: 10.1016/j.bbi.2010.10.004  0.68
2011 Ribolsi M, Mori F, Magni V, Codecà C, Kusayanagi H, Monteleone F, Rubino IA, Siracusano A, Bernardi G, Centonze D, Koch G. Impaired inter-hemispheric facilitatory connectivity in schizophrenia. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 122: 512-7. PMID 20864396 DOI: 10.1016/j.clinph.2010.08.013  0.68
2010 Berger JR, Centonze D, Comi G, Confavreux C, Cutter G, Giovannoni G, Gold R, Hartung HP, Lublin F, Miravalle A, Montalban X, O'Connor P, Olsson T, Polman CH, Stuve O, et al. Considerations on discontinuing natalizumab for the treatment of multiple sclerosis. Annals of Neurology. 68: 409-11. PMID 20818795 DOI: 10.1002/ana.22083  0.68
2010 D'Aguanno S, Franciotta D, Lupisella S, Barassi A, Pieragostino D, Lugaresi A, Centonze D, D'Eril GM, Bernardini S, Federici G, Urbani A. Protein profiling of Guillain-Barrè syndrome cerebrospinal fluid by two-dimensional electrophoresis and mass spectrometry. Neuroscience Letters. 485: 49-54. PMID 20801190 DOI: 10.1016/j.neulet.2010.08.060  0.68
2010 Napolitano F, Bonito-Oliva A, Federici M, Carta M, Errico F, Magara S, Martella G, Nisticò R, Centonze D, Pisani A, Gu HH, Mercuri NB, Usiello A. Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 11043-56. PMID 20720111 DOI: 10.1523/JNEUROSCI.1682-10.2010  0.68
2010 Codecà C, Mori F, Kusayanagi H, Monteleone F, Boffa L, Paolillo A, Bernardi G, Koch G, Centonze D. Differential patterns of interhemispheric functional disconnection in mild and advanced multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 16: 1308-16. PMID 20702503 DOI: 10.1177/1352458510376957  0.68
2010 Rossi S, De Chiara V, Furlan R, Musella A, Cavasinni F, Muzio L, Bernardi G, Martino G, Centonze D. Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis. Brain, Behavior, and Immunity. 24: 1379-85. PMID 20647042 DOI: 10.1016/j.bbi.2010.07.241  0.68
2010 Mandolesi G, Grasselli G, Musumeci G, Centonze D. Cognitive deficits in experimental autoimmune encephalomyelitis: neuroinflammation and synaptic degeneration. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 31: S255-9. PMID 20635112 DOI: 10.1007/s10072-010-0369-3  0.68
2010 De Chiara V, Angelucci F, Rossi S, Musella A, Cavasinni F, Cantarella C, Mataluni G, Sacchetti L, Napolitano F, Castelli M, Caltagirone C, Bernardi G, Maccarrone M, Usiello A, Centonze D. Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 8127-37. PMID 20554863 DOI: 10.1523/JNEUROSCI.1683-10.2010  0.68
2010 Rossi S, De Chiara V, Musella A, Sacchetti L, Cantarella C, Castelli M, Cavasinni F, Motta C, Studer V, Bernardi G, Cravatt BF, Maccarrone M, Usiello A, Centonze D. Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition. Molecular Pharmacology. 78: 260-8. PMID 20424126 DOI: 10.1124/mol.110.064196  0.68
2010 Maccarrone M, Rossi S, Bari M, De Chiara V, Rapino C, Musella A, Bernardi G, Bagni C, Centonze D. Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1500-9. PMID 20393458 DOI: 10.1038/npp.2010.19  0.68
2010 Rossi S, Bernardi G, Centonze D. The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis. Experimental Neurology. 224: 92-102. PMID 20353778 DOI: 10.1016/j.expneurol.2010.03.030  0.68
2010 Musella A, De Chiara V, Rossi S, Cavasinni F, Castelli M, Cantarella C, Mataluni G, Bernardi G, Centonze D. Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum. Neuroscience. 167: 864-71. PMID 20219639 DOI: 10.1016/j.neuroscience.2010.02.058  0.68
2010 Rossi S, De Chiara V, Musella A, Mataluni G, Sacchetti L, Siracusano A, Bernardi G, Usiello A, Centonze D. Effects of caffeine on striatal neurotransmission: focus on cannabinoid CB1 receptors. Molecular Nutrition & Food Research. 54: 525-31. PMID 20087854 DOI: 10.1002/mnfr.200900237  0.68
2010 Mori F, Codecà C, Kusayanagi H, Monteleone F, Buttari F, Fiore S, Bernardi G, Koch G, Centonze D. Effects of anodal transcranial direct current stimulation on chronic neuropathic pain in patients with multiple sclerosis. The Journal of Pain : Official Journal of the American Pain Society. 11: 436-42. PMID 20018567 DOI: 10.1016/j.jpain.2009.08.011  0.68
2010 Spanò B, Cercignani M, Basile B, Romano S, Mannu R, Centonze D, Caltagirone C, Bramanti P, Nocentini U, Bozzali M. Multiparametric MR investigation of the motor pyramidal system in patients with 'truly benign' multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 16: 178-88. PMID 20007429 DOI: 10.1177/1352458509356010  0.68
2010 Centonze D, Muzio L, Rossi S, Furlan R, Bernardi G, Martino G. The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis. Cell Death and Differentiation. 17: 1083-91. PMID 19927157 DOI: 10.1038/cdd.2009.179  0.68
2010 Mori F, Codecà C, Kusayanagi H, Monteleone F, Boffa L, Rimano A, Bernardi G, Koch G, Centonze D. Effects of intermittent theta burst stimulation on spasticity in patients with multiple sclerosis. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 17: 295-300. PMID 19863647 DOI: 10.1111/j.1468-1331.2009.02806.x  0.68
2010 De Chiara V, Errico F, Musella A, Rossi S, Mataluni G, Sacchetti L, Siracusano A, Castelli M, Cavasinni F, Bernardi G, Usiello A, Centonze D. Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 374-87. PMID 19776732 DOI: 10.1038/npp.2009.141  0.68
2010 Rossi S, De Chiara V, Musella A, Cozzolino M, Bernardi G, Maccarrone M, Mercuri NB, Carrì MT, Centonze D. Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 11: 83-90. PMID 19452308 DOI: 10.3109/17482960902977954  0.68
2009 Koch G, Mori F, Codecà C, Kusayanagi H, Monteleone F, Buttari F, Fiore S, Bernardi G, Centonze D. Cannabis-based treatment induces polarity-reversing plasticity assessed by theta burst stimulation in humans. Brain Stimulation. 2: 229-33. PMID 20633421 DOI: 10.1016/j.brs.2009.03.001  0.68
2009 Errico F, Napolitano F, Nisticò R, Centonze D, Usiello A. D-aspartate: an atypical amino acid with neuromodulatory activity in mammals. Reviews in the Neurosciences. 20: 429-40. PMID 20397623  0.68
2009 Centonze D, Mori F, Koch G, Buttari F, Codecà C, Rossi S, Cencioni MT, Bari M, Fiore S, Bernardi G, Battistini L, Maccarrone M. Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 30: 531-4. PMID 19768368 DOI: 10.1007/s10072-009-0136-5  0.68
2009 D'Argenzio L, Koch G, Bombardieri R, Mori F, Moavero R, Centonze D, Curatolo P. Abnormal parieto-motor connectivity in Tuberous Sclerosis Complex. Epilepsy Research. 87: 102-5. PMID 19713078 DOI: 10.1016/j.eplepsyres.2009.07.009  0.68
2009 Fazio R, Malosio ML, Lampasona V, De Feo D, Privitera D, Marnetto F, Centonze D, Ghezzi A, Comi G, Furlan R, Martino G. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients. Multiple Sclerosis (Houndmills, Basingstoke, England). 15: 1153-63. PMID 19667009 DOI: 10.1177/1352458509106851  0.68
2009 Mori F, Koch G, Foti C, Bernardi G, Centonze D. The use of repetitive transcranial magnetic stimulation (rTMS) for the treatment of spasticity. Progress in Brain Research. 175: 429-39. PMID 19660671 DOI: 10.1016/S0079-6123(09)17528-3  0.68
2009 Rossi S, Furlan R, De Chiara V, Musella A, Lo Giudice T, Mataluni G, Cavasinni F, Cantarella C, Bernardi G, Muzio L, Martorana A, Martino G, Centonze D. Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis. Neurobiology of Disease. 36: 51-9. PMID 19591937 DOI: 10.1016/j.nbd.2009.06.013  0.68
2009 Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Goretti B, Caniatti L, Di Monte E, Ferrazza P, Brescia Morra V, Lo Fermo S, Picconi O, Luccichenti G, Vecchio R, Maimone D, ... ... Centonze D, et al. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: Baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study Multiple Sclerosis. 15: 779-788. PMID 19542262 DOI: 10.1177/1352458509105544  0.68
2009 Ribolsi M, Koch G, Magni V, Di Lorenzo G, Rubino IA, Siracusano A, Centonze D. Abnormal brain lateralization and connectivity in schizophrenia. Reviews in the Neurosciences. 20: 61-70. PMID 19526734  0.68
2009 Ammatuna E, Montefusco E, Pacilli M, Divona M, Ardiri D, Centonze D, Lo-Coco F. Use of arsenic trioxide in secondary acute promyelocytic leukemia developing after treatment of multiple sclerosis with mitoxantrone. Leukemia & Lymphoma. 50: 1217-8. PMID 19479616 DOI: 10.1080/10428190902912486  0.68
2009 Centonze D, Bari M, Di Michele B, Rossi S, Gasperi V, Pasini A, Battista N, Bernardi G, Curatolo P, Maccarrone M. Altered anandamide degradation in attention-deficit/hyperactivity disorder. Neurology. 72: 1526-7. PMID 19398708 DOI: 10.1212/WNL.0b013e3181a2e8f6  0.68
2009 Rossi S, Mataluni G, Codecà C, Fiore S, Buttari F, Musella A, Castelli M, Bernardi G, Centonze D. Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 16: 360-6. PMID 19364364 DOI: 10.1111/j.1468-1331.2008.02496.x  0.68
2009 Centonze D, Muzio L, Rossi S, Cavasinni F, De Chiara V, Bergami A, Musella A, D'Amelio M, Cavallucci V, Martorana A, Bergamaschi A, Cencioni MT, Diamantini A, Butti E, Comi G, et al. Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 3442-52. PMID 19295150 DOI: 10.1523/JNEUROSCI.5804-08.2009  0.68
2009 Rossi S, De Chiara V, Musella A, Mataluni G, Sacchetti L, Bernardi G, Usiello A, Centonze D. Adaptations of striatal endocannabinoid system during stress. Molecular Neurobiology. 39: 178-84. PMID 19267225 DOI: 10.1007/s12035-009-8061-4  0.68
2009 Maccarrone M, De Chiara V, Gasperi V, Viscomi MT, Rossi S, Oddi S, Molinari M, Musella A, Finazzi-Agrò A, Centonze D. Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum. Journal of Neurochemistry. 109: 371-81. PMID 19187444 DOI: 10.1111/j.1471-4159.2009.05948.x  0.68
2009 Rossi S, De Chiara V, Musella A, Mataluni G, Sacchetti L, Siracusano A, Bernardi G, Usiello A, Centonze D. Caffeine drinking potentiates cannabinoid transmission in the striatum: interaction with stress effects. Neuropharmacology. 56: 590-7. PMID 19027757 DOI: 10.1016/j.neuropharm.2008.10.013  0.68
2009 Tashev R, Moura PJ, Venkitaramani DV, Prosperetti C, Centonze D, Paul S, Lombroso PJ. A substrate trapping mutant form of striatal-enriched protein tyrosine phosphatase prevents amphetamine-induced stereotypies and long-term potentiation in the striatum. Biological Psychiatry. 65: 637-45. PMID 19026408 DOI: 10.1016/j.biopsych.2008.10.008  0.68
2009 Musella A, De Chiara V, Rossi S, Prosperetti C, Bernardi G, Maccarrone M, Centonze D. TRPV1 channels facilitate glutamate transmission in the striatum. Molecular and Cellular Neurosciences. 40: 89-97. PMID 18930149 DOI: 10.1016/j.mcn.2008.09.001  0.68
2008 Rossi S, Mataluni G, De Bartolo P, Prosperetti C, Foti F, De Chiara V, Musella A, Mandolesi L, Bernardi G, Centonze D, Petrosini L. Cerebellar control of cortico-striatal LTD. Restorative Neurology and Neuroscience. 26: 475-80. PMID 19096135  0.68
2008 Errico F, Rossi S, Napolitano F, Catuogno V, Topo E, Fisone G, D'Aniello A, Centonze D, Usiello A. D-aspartate prevents corticostriatal long-term depression and attenuates schizophrenia-like symptoms induced by amphetamine and MK-801. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 10404-14. PMID 18842900 DOI: 10.1523/JNEUROSCI.1618-08.2008  0.68
2008 Centonze D, Battistini L, Maccarrone M. The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases. Current Pharmaceutical Design. 14: 2370-42. PMID 18781987 DOI: 10.2174/138161208785740018  0.68
2008 Centonze D, Furlan R, Gasperini C, Salvetti M, Battistini L. Early relapses after the first dose of natalizumab in active multiple sclerosis patients. Multiple Sclerosis (Houndmills, Basingstoke, England). 14: 1137-8. PMID 18701574 DOI: 10.1177/1352458508092810  0.68
2008 Rossi S, De Chiara V, Musella A, Kusayanagi H, Mataluni G, Bernardi G, Usiello A, Centonze D. Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 7284-92. PMID 18632932 DOI: 10.1523/JNEUROSCI.5346-07.2008  0.68
2008 Koch G, Ribolsi M, Mori F, Sacchetti L, Codecà C, Rubino IA, Siracusano A, Bernardi G, Centonze D. Connectivity between posterior parietal cortex and ipsilateral motor cortex is altered in schizophrenia. Biological Psychiatry. 64: 815-9. PMID 18632089 DOI: 10.1016/j.biopsych.2008.05.026  0.68
2008 Koch G, Rossi S, Prosperetti C, Codecà C, Monteleone F, Petrosini L, Bernardi G, Centonze D. Improvement of hand dexterity following motor cortex rTMS in multiple sclerosis patients with cerebellar impairment. Multiple Sclerosis (Houndmills, Basingstoke, England). 14: 995-8. PMID 18573820 DOI: 10.1177/1352458508088710  0.68
2008 Centonze D, Rossi S, De Bartolo P, De Chiara V, Foti F, Musella A, Mataluni G, Rossi S, Bernardi G, Koch G, Petrosini L. Adaptations of glutamatergic synapses in the striatum contribute to recovery from cerebellar damage. The European Journal of Neuroscience. 27: 2188-96. PMID 18412636 DOI: 10.1111/j.1460-9568.2008.06182.x  0.68
2008 Napolitano M, Zei D, Centonze D, Palermo R, Bernardi G, Vacca A, Calabresi P, Gulino A. NF-kB/NOS cross-talk induced by mitochondrial complex II inhibition: implications for Huntington's disease. Neuroscience Letters. 434: 241-6. PMID 18329171 DOI: 10.1016/j.neulet.2007.09.056  0.68
2008 Maccarrone M, Rossi S, Bari M, De Chiara V, Fezza F, Musella A, Gasperi V, Prosperetti C, Bernardi G, Finazzi-Agrò A, Cravatt BF, Centonze D. Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nature Neuroscience. 11: 152-9. PMID 18204441 DOI: 10.1038/nn2042  0.68
2008 Errico F, Santini E, Migliarini S, Borgkvist A, Centonze D, Nasti V, Carta M, De Chiara V, Prosperetti C, Spano D, Herve D, Pasqualetti M, Di Lauro R, Fisone G, Usiello A. The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons. Molecular and Cellular Neurosciences. 37: 335-45. PMID 18035555 DOI: 10.1016/j.mcn.2007.10.007  0.68
2008 Centonze D, Rossi S, Mercaldo V, Napoli I, Ciotti MT, De Chiara V, Musella A, Prosperetti C, Calabresi P, Bernardi G, Bagni C. Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome. Biological Psychiatry. 63: 963-73. PMID 18028882 DOI: 10.1016/j.biopsych.2007.09.008  0.68
2008 Errico F, Nisticò R, Palma G, Federici M, Affuso A, Brilli E, Topo E, Centonze D, Bernardi G, Bozzi Y, D'Aniello A, Di Lauro R, Mercuri NB, Usiello A. Increased levels of d-aspartate in the hippocampus enhance LTP but do not facilitate cognitive flexibility. Molecular and Cellular Neurosciences. 37: 236-46. PMID 17981050 DOI: 10.1016/j.mcn.2007.09.012  0.68
2008 Bari M, Oddi S, De Simone C, Spagnolo P, Gasperi V, Battista N, Centonze D, Maccarrone M. Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells. Neuropharmacology. 54: 45-50. PMID 17714745 DOI: 10.1016/j.neuropharm.2007.06.030  0.68
2007 Sallustio F, Diomedi M, Centonze D, Stanzione P. Saving the ischemic penumbra: potential role for statins and phosphodiesterase inhibitors. Current Vascular Pharmacology. 5: 259-65. PMID 17979792 DOI: 10.2174/157016107782023424  0.68
2007 Centonze D, Bernardi G, Koch G. Mechanisms of disease: basic-research-driven investigations in humans--the case of hyperkinetic disorders. Nature Clinical Practice. Neurology. 3: 572-80. PMID 17914345 DOI: 10.1038/ncpneuro0617  0.68
2007 Tozzi A, Tscherter A, Belcastro V, Tantucci M, Costa C, Picconi B, Centonze D, Calabresi P, Borsini F. Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission. Neuropharmacology. 53: 783-9. PMID 17889039 DOI: 10.1016/j.neuropharm.2007.08.006  0.68
2007 Centonze D, Rossi S, Napoli I, Mercaldo V, Lacoux C, Ferrari F, Ciotti MT, De Chiara V, Prosperetti C, Maccarrone M, Fezza F, Calabresi P, Bernardi G, Bagni C. The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 8885-92. PMID 17699670 DOI: 10.1523/JNEUROSCI.0548-07.2007  0.68
2007 Centonze D, Rossi S, Finazzi-Agrò A, Bernardi G, Maccarrone M. The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis. International Review of Neurobiology. 82: 171-86. PMID 17678961 DOI: 10.1016/S0074-7742(07)82009-5  0.68
2007 Centonze D, Bari M, Rossi S, Prosperetti C, Furlan R, Fezza F, De Chiara V, Battistini L, Bernardi G, Bernardini S, Martino G, Maccarrone M. The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. Brain : a Journal of Neurology. 130: 2543-53. PMID 17626034 DOI: 10.1093/brain/awm160  0.68
2007 Centonze D, Rossi S, Tortiglione A, Picconi B, Prosperetti C, De Chiara V, Bernardi G, Calabresi P. Synaptic plasticity during recovery from permanent occlusion of the middle cerebral artery. Neurobiology of Disease. 27: 44-53. PMID 17490888 DOI: 10.1016/j.nbd.2007.03.012  0.68
2007 Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, Höpner S, Centonze D, Bernardi G, Dell'Acqua ML, Rossini PM, Battistini L, Rötzschke O, Falk K. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood. 110: 1225-32. PMID 17449799 DOI: 10.1182/blood-2006-12-064527  0.68
2007 Centonze D, Petta F, Versace V, Rossi S, Torelli F, Prosperetti C, Rossi S, Marfia GA, Bernardi G, Koch G, Miano R, Boffa L, Finazzi-Agrò E. Effects of motor cortex rTMS on lower urinary tract dysfunction in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13: 269-71. PMID 17439897 DOI: 10.1177/1352458506070729  0.76
2007 Centonze D, Rossi S, Prosperetti C, Gasperi V, De Chiara V, Bari M, Tscherter A, Febbraro F, Bernardi G, Maccarrone M. Endocannabinoids limit metabotropic glutamate 5 receptor-mediated synaptic inhibition of striatal principal neurons. Molecular and Cellular Neurosciences. 35: 302-10. PMID 17434747 DOI: 10.1016/j.mcn.2007.03.005  0.68
2007 Centonze D, Rossi S, De Chiara V, Prosperetti C, Battista N, Bernardi G, Mercuri NB, Usiello A, Maccarrone M. Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors. The European Journal of Neuroscience. 25: 1631-40. PMID 17408430 DOI: 10.1111/j.1460-9568.2007.05433.x  0.68
2007 Tortiglione A, Picconi B, Barone I, Centonze D, Rossi S, Costa C, Di Filippo M, Tozzi A, Tantucci M, Bernardi G, Annunziato L, Calabresi P. Na+/Ca2+ exchanger maintains ionic homeostasis in the peri-infarct area. Stroke; a Journal of Cerebral Circulation. 38: 1614-20. PMID 17395860 DOI: 10.1161/STROKEAHA.106.478644  0.68
2007 Centonze D, Koch G, Versace V, Mori F, Rossi S, Brusa L, Grossi K, Torelli F, Prosperetti C, Cervellino A, Marfia GA, Stanzione P, Marciani MG, Boffa L, Bernardi G. Repetitive transcranial magnetic stimulation of the motor cortex ameliorates spasticity in multiple sclerosis. Neurology. 68: 1045-50. PMID 17389310 DOI: 10.1212/01.wnl.0000257818.16952.62  0.76
2007 Garaci FG, Colangelo V, Ludovici A, Gaudiello F, Marziali S, Centonze D, Boffa L, Simonetti G, Floris R. A diffusion longitudinal MR imaging study in normal-appearing white matter in untreated relapsing-remitting multiple sclerosis. Ajnr. American Journal of Neuroradiology. 28: 475-8. PMID 17353315  0.48
2007 Centonze D, Finazzi-Agrò A, Bernardi G, Maccarrone M. The endocannabinoid system in targeting inflammatory neurodegenerative diseases. Trends in Pharmacological Sciences. 28: 180-7. PMID 17350694 DOI: 10.1016/j.tips.2007.02.004  0.76
2007 Maccarrone M, Battista N, Centonze D. The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases. Progress in Neurobiology. 81: 349-79. PMID 17276576 DOI: 10.1016/j.pneurobio.2006.11.006  0.48
2006 Rossi S, Prosperetti C, Picconi B, De Chiara V, Mataluni G, Bernardi G, Calabresi P, Centonze D. Deficits of glutamate transmission in the striatum of toxic and genetic models of Huntington's disease. Neuroscience Letters. 410: 6-10. PMID 17070651 DOI: 10.1016/j.neulet.2006.09.056  0.76
2006 Centonze D, Rossi S, Gubellini P, De Chiara V, Tscherter A, Prosperetti C, Picconi B, Bernardi G, Calabresi P, Baunez C. Deficits of glutamate transmission in the striatum of experimental hemiballism. Neuroscience. 143: 213-21. PMID 16938405 DOI: 10.1016/j.neuroscience.2006.07.024  0.68
2006 Centonze D, Prosperetti C, Barone I, Rossi S, Picconi B, Tscherter A, De Chiara V, Bernardi G, Calabresi P. NR2B-containing NMDA receptors promote the neurotoxic effects of 3-nitropropionic acid but not of rotenone in the striatum. Experimental Neurology. 202: 470-9. PMID 16919272 DOI: 10.1016/j.expneurol.2006.07.009  0.68
2006 Brusa L, Versace V, Koch G, Iani C, Stanzione P, Bernardi G, Centonze D. Low frequency rTMS of the SMA transiently ameliorates peak-dose LID in Parkinson's disease. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 117: 1917-21. PMID 16887383 DOI: 10.1016/j.clinph.2006.03.033  0.76
2006 Picconi B, Tortiglione A, Barone I, Centonze D, Gardoni F, Gubellini P, Bonsi P, Pisani A, Bernardi G, Di Luca M, Calabresi P. NR2B subunit exerts a critical role in postischemic synaptic plasticity. Stroke; a Journal of Cerebral Circulation. 37: 1895-901. PMID 16741178 DOI: 10.1161/01.STR.0000226981.57777.b0  0.68
2006 Allen PB, Zachariou V, Svenningsson P, Lepore AC, Centonze D, Costa C, Rossi S, Bender G, Chen G, Feng J, Snyder GL, Bernardi G, Nestler EJ, Yan Z, Calabresi P, et al. Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity. Neuroscience. 140: 897-911. PMID 16600521 DOI: 10.1016/j.neuroscience.2006.02.067  0.68
2006 Napolitano M, Picconi B, Centonze D, Bernardi G, Calabresi P, Gulino A. L-DOPA treatment of parkinsonian rats changes the expression of Src, Lyn and PKC kinases. Neuroscience Letters. 398: 211-4. PMID 16529858 DOI: 10.1016/j.neulet.2005.12.077  0.76
2006 Centonze D, Costa C, Rossi S, Prosperetti C, Pisani A, Usiello A, Bernardi G, Mercuri NB, Calabresi P. Chronic cocaine prevents depotentiation at corticostriatal synapses. Biological Psychiatry. 60: 436-43. PMID 16476411 DOI: 10.1016/j.biopsych.2005.11.018  0.68
2005 Centonze D, Siracusano A, Calabresi P, Bernardi G. Removing pathogenic memories: a neurobiology of psychotherapy. Molecular Neurobiology. 32: 123-32. PMID 16215277 DOI: 10.1385/MN:32:2:123  0.76
2005 Brusa L, Versace V, Koch G, Bernardi G, Iani C, Stanzione P, Centonze D. Improvement of choreic movements by 1 Hz repetitive transcranial magnetic stimulation in Huntington's disease patients. Annals of Neurology. 58: 655-6. PMID 16178020 DOI: 10.1002/ana.20613  0.76
2005 Koch G, Brusa L, Caltagirone C, Peppe A, Oliveri M, Stanzione P, Centonze D. rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease. Neurology. 65: 623-5. PMID 16116131 DOI: 10.1212/01.wnl.0000172861.36430.95  0.48
2005 Bonsi P, Cuomo D, De Persis C, Centonze D, Bernardi G, Calabresi P, Pisani A. Modulatory action of metabotropic glutamate receptor (mGluR) 5 on mGluR1 function in striatal cholinergic interneurons. Neuropharmacology. 49: 104-13. PMID 16005029 DOI: 10.1016/j.neuropharm.2005.05.012  0.76
2005 Centonze D, Rossi S, Prosperetti C, Tscherter A, Bernardi G, Maccarrone M, Calabresi P. Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice. Biological Psychiatry. 57: 1583-9. PMID 15953496 DOI: 10.1016/j.biopsych.2005.03.008  0.68
2005 Picconi B, Pisani A, Barone I, Bonsi P, Centonze D, Bernardi G, Calabresi P. Pathological synaptic plasticity in the striatum: implications for Parkinson's disease. Neurotoxicology. 26: 779-83. PMID 15927256 DOI: 10.1016/j.neuro.2005.02.002  0.68
2005 Centonze D, Gubellini P, Rossi S, Picconi B, Pisani A, Bernardi G, Calabresi P, Baunez C. Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism. Neuroscience. 133: 831-40. PMID 15893432 DOI: 10.1016/j.neuroscience.2005.03.006  0.68
2005 Centonze D, Palmieri MG, Boffa L, Pierantozzi M, Stanzione P, Brusa L, Marciani M, Siracusano A, Bernardi G, Caramia M. Cortical hyperexcitability in post-traumatic stress disorder secondary to minor accidental head trauma: a neurophysiologic study. Journal of Psychiatry & Neuroscience : Jpn. 30: 127-32. PMID 15798788  0.76
2005 Pisani A, Centonze D, Bernardi G, Calabresi P. Striatal synaptic plasticity: implications for motor learning and Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 395-402. PMID 15719415 DOI: 10.1002/mds.20394  0.76
2005 Centonze D, Rossi S, Boffa L, Versace V, Palmieri MG, Caramia MD, Bernardi G. CSF from MS patients can induce acute conduction block in the isolated optic nerve. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 12: 45-8. PMID 15613146 DOI: 10.1111/j.1468-1331.2004.00946.x  0.76
2005 Centonze D, Siracusano A, Calabresi P, Bernardi G. Long-term potentiation and memory processes in the psychological works of Sigmund Freud and in the formation of neuropsychiatric symptoms. Neuroscience. 130: 559-65. PMID 15590140 DOI: 10.1016/j.neuroscience.2004.09.032  0.76
2004 Gubellini P, Pisani A, Centonze D, Bernardi G, Calabresi P. Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases. Progress in Neurobiology. 74: 271-300. PMID 15582223 DOI: 10.1016/j.pneurobio.2004.09.005  0.76
2004 Centonze D, Siracusano A, Calabresi P, Bernardi G. The Project for a Scientific Psychology (1895): a Freudian anticipation of LTP-memory connection theory. Brain Research. Brain Research Reviews. 46: 310-4. PMID 15571772 DOI: 10.1016/j.brainresrev.2004.07.006  0.76
2004 Centonze D, Gubellini P, Usiello A, Rossi S, Tscherter A, Bracci E, Erbs E, Tognazzi N, Bernardi G, Pisani A, Calabresi P, Borrelli E. Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum. Neuroscience. 129: 157-66. PMID 15489038 DOI: 10.1016/j.neuroscience.2004.07.043  0.68
2004 Centonze D, Usiello A, Costa C, Picconi B, Erbs E, Bernardi G, Borrelli E, Calabresi P. Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 8214-22. PMID 15385604 DOI: 10.1523/JNEUROSCI.1274-04.2004  0.76
2004 Bracci E, Centonze D, Bernardi G, Calabresi P. Engagement of rat striatal neurons by cortical epileptiform activity investigated with paired recordings. Journal of Neurophysiology. 92: 2725-37. PMID 15240765 DOI: 10.1152/jn.00585.2004  0.68
2004 Picconi B, Gardoni F, Centonze D, Mauceri D, Cenci MA, Bernardi G, Calabresi P, Di Luca M. Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 5283-91. PMID 15190099 DOI: 10.1523/JNEUROSCI.1224-04.2004  0.68
2004 Picconi B, Centonze D, Rossi S, Bernardi G, Calabresi P. Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism. Brain : a Journal of Neurology. 127: 1661-9. PMID 15155524 DOI: 10.1093/brain/awh190  0.76
2004 Centonze D, Battista N, Rossi S, Mercuri NB, Finazzi-Agrò A, Bernardi G, Calabresi P, Maccarrone M. A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 1488-97. PMID 15100701 DOI: 10.1038/sj.npp.1300458  0.68
2004 Gubellini P, Centonze D, Tropepi D, Bernardi G, Calabresi P. Induction of corticostriatal LTP by 3-nitropropionic acid requires the activation of mGluR1/PKC pathway. Neuropharmacology. 46: 761-9. PMID 15033336 DOI: 10.1016/j.neuropharm.2003.11.021  0.76
2004 Napolitano M, Centonze D, Gubellini P, Rossi S, Spiezia S, Bernardi G, Gulino A, Calabresi P. Inhibition of mitochondrial complex II alters striatal expression of genes involved in glutamatergic and dopaminergic signaling: possible implications for Huntington's disease. Neurobiology of Disease. 15: 407-14. PMID 15006711 DOI: 10.1016/j.nbd.2003.11.021  0.76
2004 Caramia MD, Palmieri MG, Desiato MT, Boffa L, Galizia P, Rossini PM, Centonze D, Bernardi G. Brain excitability changes in the relapsing and remitting phases of multiple sclerosis: a study with transcranial magnetic stimulation. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 115: 956-65. PMID 15003779 DOI: 10.1016/j.clinph.2003.11.024  0.76
2004 Saulle E, Gubellini P, Picconi B, Centonze D, Tropepi D, Pisani A, Morari M, Marti M, Rossi L, Papa M, Bernardi G, Calabresi P. Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease. Molecular and Cellular Neurosciences. 25: 9-20. PMID 14962736 DOI: 10.1016/j.mcn.2003.09.013  0.76
2004 Bonsi P, Calabresi P, De Persis C, Papa M, Centonze D, Bernardi G, Pisani A. Early ionic and membrane potential changes caused by the pesticide rotenone in striatal cholinergic interneurons. Experimental Neurology. 185: 169-81. PMID 14697328  0.76
2003 Centonze D, Gubellini P, Pisani A, Bernardi G, Calabresi P. Dopamine, acetylcholine and nitric oxide systems interact to induce corticostriatal synaptic plasticity. Reviews in the Neurosciences. 14: 207-16. PMID 14513864  0.76
2003 Calabresi P, Centonze D, Pisani A, Cupini L, Bernardi G. Synaptic plasticity in the ischaemic brain. The Lancet. Neurology. 2: 622-9. PMID 14505584  0.76
2003 Centonze D, Grande C, Saulle E, Martin AB, Gubellini P, Pavón N, Pisani A, Bernardi G, Moratalla R, Calabresi P. Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 8506-12. PMID 13679419  0.68
2003 Calabresi P, Marti M, Picconi B, Saulle E, Costa C, Centonze D, Pisani F, Bernardi G. Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study. Experimental Neurology. 182: 461-9. PMID 12895457  0.76
2003 Centonze D, Grande C, Usiello A, Gubellini P, Erbs E, Martin AB, Pisani A, Tognazzi N, Bernardi G, Moratalla R, Borrelli E, Calabresi P. Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 6245-54. PMID 12867509  0.68
2003 Pisani A, Bonsi P, Centonze D, Martorana A, Fusco F, Sancesario G, De Persis C, Bernardi G, Calabresi P. Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 5272-82. PMID 12832552  0.76
2003 Pisani A, Bonsi P, Centonze D, Gubellini P, Bernardi G, Calabresi P. Targeting striatal cholinergic interneurons in Parkinson's disease: focus on metabotropic glutamate receptors. Neuropharmacology. 45: 45-56. PMID 12814658  0.76
2003 Calabresi P, Cupini LM, Centonze D, Pisani F, Bernardi G. Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia. Annals of Neurology. 53: 693-702. PMID 12783414 DOI: 10.1002/ana.10603  0.76
2003 Maccarrone M, Gubellini P, Bari M, Picconi B, Battista N, Centonze D, Bernardi G, Finazzi-Agrò A, Calabresi P. Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism. Journal of Neurochemistry. 85: 1018-25. PMID 12716433  0.76
2003 Picconi B, Centonze D, HÃ¥kansson K, Bernardi G, Greengard P, Fisone G, Cenci MA, Calabresi P. Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nature Neuroscience. 6: 501-6. PMID 12665799 DOI: 10.1038/nn1040  0.76
2003 Bracci E, Centonze D, Bernardi G, Calabresi P. Voltage-dependent membrane potential oscillations of rat striatal fast-spiking interneurons. The Journal of Physiology. 549: 121-30. PMID 12665602 DOI: 10.1113/jphysiol.2003.040857  0.68
2003 Calabresi P, Centonze D, Cupini LM, Costa C, Pisani F, Bernardi G. Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies. Neurobiology of Disease. 12: 82-8. PMID 12609492  0.76
2003 Gubellini P, Saulle E, Centonze D, Costa C, Tropepi D, Bernardi G, Conquet F, Calabresi P. Corticostriatal LTP requires combined mGluR1 and mGluR5 activation. Neuropharmacology. 44: 8-16. PMID 12559117  0.76
2003 Tofighy A, Abbott A, Centonze D, Cooper AJ, Noor E, Pearce SM, Puntis M, Stanford IM, Wigmore MA, Lacey MG. Excitation by dopamine of rat subthalamic nucleus neurones in vitro-a direct action with unconventional pharmacology. Neuroscience. 116: 157-66. PMID 12535949 DOI: 10.1016/S0306-4522(02)00546-8  0.68
2002 Saulle E, Centonze D, Martín AB, Moratalla R, Bernardi G, Calabresi P. Endogenous dopamine amplifies ischemic long-term potentiation via D1 receptors. Stroke; a Journal of Cerebral Circulation. 33: 2978-84. PMID 12468800 DOI: 10.1161/01.STR.0000038093.42512.0F  0.68
2002 Centonze D, Usiello A, Gubellini P, Pisani A, Borrelli E, Bernardi G, Calabresi P. Dopamine D2 receptor-mediated inhibition of dopaminergic neurons in mice lacking D2L receptors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 27: 723-6. PMID 12431847 DOI: 10.1016/S0893-133X(02)00367-6  0.76
2002 Picconi B, Pisani A, Centonze D, Battaglia G, Storto M, Nicoletti F, Bernardi G, Calabresi P. Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment. Brain : a Journal of Neurology. 125: 2635-45. PMID 12429591  0.76
2002 Napolitano M, Centonze D, Calce A, Picconi B, Spiezia S, Gulino A, Bernardi G, Calabresi P. Experimental parkinsonism modulates multiple genes involved in the transduction of dopaminergic signals in the striatum. Neurobiology of Disease. 10: 387-95. PMID 12270699  0.76
2002 Centonze D, Napolitano M, Saulle E, Gubellini P, Picconi B, Martorana A, Pisani A, Gulino A, Bernardi G, Calabresi P. Tissue plasminogen activator is required for corticostriatal long-term potentiation. The European Journal of Neuroscience. 16: 713-21. PMID 12270047  0.76
2002 Gubellini P, Picconi B, Bari M, Battista N, Calabresi P, Centonze D, Bernardi G, Finazzi-Agrò A, Maccarrone M. Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 6900-7. PMID 12177188  0.76
2002 Pisani A, Bonsi P, Catania MV, Giuffrida R, Morari M, Marti M, Centonze D, Bernardi G, Kingston AE, Calabresi P. Metabotropic glutamate 2 receptors modulate synaptic inputs and calcium signals in striatal cholinergic interneurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 6176-85. PMID 12122076  0.76
2002 Centonze D, Bracci E, Pisani A, Gubellini P, Bernardi G, Calabresi P. Activation of dopamine D1-like receptors excites LTS interneurons of the striatum. The European Journal of Neuroscience. 15: 2049-52. PMID 12099911 DOI: 10.1046/j.1460-9568.2002.02052.x  0.68
2002 Bracci E, Centonze D, Bernardi G, Calabresi P. Dopamine excites fast-spiking interneurons in the striatum. Journal of Neurophysiology. 87: 2190-4. PMID 11929936 DOI: 10.1152/jn.00754.2001  0.68
2002 Centonze D, Saulle E, Pisani A, Bonsi P, Tropepi D, Bernardi G, Calabresi P. Tissue plasminogen activator is required for striatal post-ischemic synaptic potentiation. Neuroreport. 13: 115-8. PMID 11924871  0.76
2002 Calabresi P, Saulle E, Centonze D, Pisani A, Marfia GA, Bernardi G. Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability. Brain : a Journal of Neurology. 125: 844-60. PMID 11912117  0.76
2002 Centonze D, Picconi B, Baunez C, Borrelli E, Pisani A, Bernardi G, Calabresi P. Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 164-75. PMID 11790512 DOI: 10.1016/S0893-133X(01)00299-8  0.68
2001 Centonze D, Saulle E, Bernardi G, Calabresi P. Receptor and post-receptor mechanisms of ischemic long-term potentiation in the striatum. Functional Neurology. 16: 149-52. PMID 11996510  0.76
2001 Centonze D, Gubellini P, Bernardi G, Calabresi P. Impaired excitatory transmission in the striatum of rats chronically intoxicated with manganese. Experimental Neurology. 172: 469-76. PMID 11716571 DOI: 10.1006/exnr.2001.7812  0.76
2001 Pisani A, Gubellini P, Bonsi P, Conquet F, Picconi B, Centonze D, Bernardi G, Calabresi P. Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons. Neuroscience. 106: 579-87. PMID 11591458  0.76
2001 Calabresi P, Saulle E, Marfia GA, Centonze D, Mulloy R, Picconi B, Hipskind RA, Conquet F, Bernardi G. Activation of metabotropic glutamate receptor subtype 1/protein kinase C/mitogen-activated protein kinase pathway is required for postischemic long-term potentiation in the striatum. Molecular Pharmacology. 60: 808-15. PMID 11562444  0.76
2001 Centonze D, Saulle E, Pisani A, Bernardi G, Calabresi P. Adenosine-mediated inhibition of striatal GABAergic synaptic transmission during in vitro ischaemia. Brain : a Journal of Neurology. 124: 1855-65. PMID 11522587  0.76
2001 Centonze D, Gubellini P, Picconi B, Saulle E, Tolu M, Bonsi P, Giacomini P, Calabresi P. An abnormal striatal synaptic plasticity may account for the selective neuronal vulnerability in Huntington's disease. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 22: 61-2. PMID 11487202  0.76
2001 Calabresi P, Ammassari-Teule M, Gubellini P, Sancesario G, Morello M, Centonze D, Marfia GA, Saulle E, Passino E, Picconi B, Bernardi G. A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication. Neurobiology of Disease. 8: 419-32. PMID 11442351 DOI: 10.1006/nbdi.2000.0379  0.76
2001 Calabresi P, Gubellini P, Picconi B, Centonze D, Pisani A, Bonsi P, Greengard P, Hipskind RA, Borrelli E, Bernardi G. Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 5110-20. PMID 11438586  0.76
2001 Battaglia G, Bruno V, Pisani A, Centonze D, Catania MV, Calabresi P, Nicoletti F. Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing gabaergic transmission. Molecular and Cellular Neurosciences. 17: 1071-83. PMID 11414795 DOI: 10.1006/mcne.2001.0992  0.76
2001 Gubellini P, Saulle E, Centonze D, Bonsi P, Pisani A, Bernardi G, Conquet F, Calabresi P. Selective involvement of mGlu1 receptors in corticostriatal LTD. Neuropharmacology. 40: 839-46. PMID 11378154  0.76
2001 Centonze D, Picconi B, Gubellini P, Bernardi G, Calabresi P. Dopaminergic control of synaptic plasticity in the dorsal striatum. The European Journal of Neuroscience. 13: 1071-7. PMID 11285003  0.76
2001 Pisani A, Bonsi P, Centonze D, Bernardi G, Calabresi P. Functional coexpression of excitatory mGluR1 and mGluR5 on striatal cholinergic interneurons. Neuropharmacology. 40: 460-3. PMID 11166340  0.76
2001 Centonze D, Marfia GA, Pisani A, Picconi B, Giacomini P, Bernardi G, Calabresi P. Ionic mechanisms underlying differential vulnerability to ischemia in striatal neurons. Progress in Neurobiology. 63: 687-96. PMID 11165001  0.76
2001 Centonze D, Pisani A, Bonsi P, Giacomini P, Bernardi G, Calabresi P. Stimulation of nitric oxide-cGMP pathway excites striatal cholinergic interneurons via protein kinase G activation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 1393-400. PMID 11160411  0.76
2000 Centonze D, Giacomini P, Tolu M, Bernardi G, Calabresi P. Possible cellular mechanism accounting for the cell type-specific vulnerability in Huntington's disease. Functional Neurology. 15: 253-8. PMID 11213528  0.76
2000 Calabresi P, Centonze D, Bernardi G. Cellular factors controlling neuronal vulnerability in the brain: a lesson from the striatum. Neurology. 55: 1249-55. PMID 11092223  0.76
2000 Calabresi P, Gubellini P, Centonze D, Picconi B, Bernardi G, Chergui K, Svenningsson P, Fienberg AA, Greengard P. Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 8443-51. PMID 11069952  0.68
2000 Calabresi P, Centonze D, Bernardi G. Electrophysiology of dopamine in normal and denervated striatal neurons. Trends in Neurosciences. 23: S57-63. PMID 11052221  0.76
2000 Pisani A, Bernardi G, Bonsi P, Centonze D, Giacomini P, Calabresi P. Cell-type specificity of mGluR activation in striatal neuronal subtypes. Amino Acids. 19: 119-29. PMID 11026480  0.76
2000 Pisani A, Bonsi P, Centonze D, Giacomini P, Calabresi P. Involvement of intracellular calcium stores during oxygen/glucose deprivation in striatal large aspiny interneurons. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 20: 839-46. PMID 10826535 DOI: 10.1097/00004647-200005000-00011  0.76
2000 Calabresi P, Napolitano M, Centonze D, Marfia GA, Gubellini P, Teule MA, Berretta N, Bernardi G, Frati L, Tolu M, Gulino A. Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory. The European Journal of Neuroscience. 12: 1002-12. PMID 10762331  0.76
2000 Calabresi P, Giacomini P, Centonze D, Bernardi G. Levodopa-induced dyskinesia: a pathological form of striatal synaptic plasticity? Annals of Neurology. 47: S60-8; discussion S6. PMID 10762133  0.76
2000 Pisani A, Bonsi P, Centonze D, Calabresi P, Bernardi G. Activation of D2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: RC69. PMID 10729358  0.76
2000 Calabresi P, Centonze D, Gubellini P, Marfia GA, Pisani A, Sancesario G, Bernardi G. Synaptic transmission in the striatum: from plasticity to neurodegeneration. Progress in Neurobiology. 61: 231-65. PMID 10727775  0.76
2000 Calabresi P, Stefani A, Marfia GA, Hainsworth AH, Centonze D, Saulle E, Spadoni F, Leach MJ, Giacomini P, Bernardi G. Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects. Experimental Neurology. 162: 171-9. PMID 10716897 DOI: 10.1006/exnr.2000.7285  0.76
2000 Calabresi P, Picconi B, Saulle E, Centonze D, Hainsworth AH, Bernardi G. Is pharmacological neuroprotection dependent on reduced glutamate release? Stroke; a Journal of Cerebral Circulation. 31: 766-72; discussion 7. PMID 10700517  0.76
2000 Calabresi P, Centonze D, Gubellini P, Pisani A, Bernardi G. Acetylcholine-mediated modulation of striatal function. Trends in Neurosciences. 23: 120-6. PMID 10675916  0.76
1999 Centonze D, Calabresi P, Giacomini P, Bernardi G. Neurophysiology of Parkinson's disease: from basic research to clinical correlates. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 110: 2006-13. PMID 10616104  0.76
1999 Centonze D, Gubellini P, Bernardi G, Calabresi P. Permissive role of interneurons in corticostriatal synaptic plasticity. Brain Research. Brain Research Reviews. 31: 1-5. PMID 10611492  0.76
1999 Centonze D, Gubellini P, Picconi B, Calabresi P, Giacomini P, Bernardi G. Unilateral dopamine denervation blocks corticostriatal LTP. Journal of Neurophysiology. 82: 3575-9. PMID 10601483  0.76
1999 Napolitano M, Marfia GA, Vacca A, Centonze D, Bellavia D, Di Marcotullio L, Frati L, Bernardi G, Gulino A, Calabresi P. Modulation of gene expression following long-term synaptic depression in the striatum. Brain Research. Molecular Brain Research. 72: 89-96. PMID 10521602  0.76
1999 Calabresi P, Centonze D, Pisani A, Bernardi G. Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: implication for ischemia and Huntington's disease. Experimental Neurology. 158: 97-108. PMID 10448421 DOI: 10.1006/exnr.1999.7092  0.76
1999 Calabresi P, Centonze D, Gubellini P, Marfia GA, Bernardi G. Glutamate-triggered events inducing corticostriatal long-term depression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 6102-10. PMID 10407046  0.76
1999 Pisani A, Calabresi P, Centonze D, Marfia GA, Bernardi G. Electrophysiological recordings and calcium measurements in striatal large aspiny interneurons in response to combined O2/glucose deprivation. Journal of Neurophysiology. 81: 2508-16. PMID 10322086  0.76
1999 Calabresi P, Centonze D, Gubellini P, Bernardi G. Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTP. Neuropharmacology. 38: 323-6. PMID 10218876  0.76
1999 Calabresi P, Centonze D, Marfia GA, Pisani A, Bernardi G. An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons. British Journal of Pharmacology. 126: 689-96. PMID 10188980 DOI: 10.1038/sj.bjp.0702361  0.76
1999 Calabresi P, Gubellini P, Centonze D, Sancesario G, Morello M, Giorgi M, Pisani A, Bernardi G. A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 2489-99. PMID 10087063  0.76
1999 Calabresi P, Marfia GA, Centonze D, Pisani A, Bernardi G. Sodium influx plays a major role in the membrane depolarization induced by oxygen and glucose deprivation in rat striatal spiny neurons. Stroke; a Journal of Cerebral Circulation. 30: 171-9. PMID 9880406  0.76
1998 Centonze D, Calabresi P, Pisani A, Marinelli S, Marfia GA, Bernardi G. Electrophysiology of the neuroprotective agent riluzole on striatal spiny neurons. Neuropharmacology. 37: 1063-70. PMID 9833635  0.76
1998 Calabresi P, Centonze D, Gubellini P, Pisani A, Bernardi G. Blockade of M2-like muscarinic receptors enhances long-term potentiation at corticostriatal synapses. The European Journal of Neuroscience. 10: 3020-3. PMID 9758172  0.76
1998 Calabresi P, Centonze D, Gubellini P, Pisani A, Bernardi G. Endogenous ACh enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation. The European Journal of Neuroscience. 10: 2887-95. PMID 9758158  0.76
1998 Calabresi P, Centonze D, Pisani A, Sancesario G, North RA, Bernardi G. Muscarinic IPSPs in rat striatal cholinergic interneurones. The Journal of Physiology. 510: 421-7. PMID 9705993 DOI: 10.1111/j.1469-7793.1998.421bk.x  0.68
1998 Pedersen JZ, Bernardi G, Centonze D, Pisani A, Rossi L, Rotilio G, Calabresi P. Hypoglycemia, hypoxia, and ischemia in a corticostriatal slice preparation: electrophysiologic changes and ascorbyl radical formation. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 18: 868-75. PMID 9701347 DOI: 10.1097/00004647-199808000-00006  0.76
1998 Calabresi P, Centonze D, Pisani A, Sancesario G, Gubellini P, Marfia GA, Bernardi G. Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease. Annals of Neurology. 43: 586-97. PMID 9585352 DOI: 10.1002/ana.410430506  0.76
1997 Calabresi P, Centonze D, Pisani A, Bernardi G. A possible mechanism for the aglycemia-induced depression of glutamatergic excitation in the striatum. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 17: 1121-6. PMID 9346437 DOI: 10.1097/00004647-199710000-00014  0.76
1997 Calabresi P, Pisani A, Centonze D, Bernardi G. Synaptic plasticity and physiological interactions between dopamine and glutamate in the striatum. Neuroscience and Biobehavioral Reviews. 21: 519-23. PMID 9195611  0.76
1997 Calabresi P, Saiardi A, Pisani A, Baik JH, Centonze D, Mercuri NB, Bernardi G, Borrelli E. Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 4536-44. PMID 9169514  0.68
1997 Calabresi P, Centonze D, Pisani A, Bernardi G. Endogenous adenosine mediates the presynaptic inhibition induced by aglycemia at corticostriatal synapses. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 4509-16. PMID 9169511  0.76
Show low-probability matches.